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ABSTRACT 
With the advent of the near ubiquitous use of antibiotics and other xenobiotics in 
food production, the potential for traces of these compounds to reside in foodstuffs 
exists. Oxytetracycline (OTC), an antibiotic fiom the tetracycline family, is widely used 
in animal husbandry and is one of the most frequently found residues in foods of animal 
origin. OTC does not undergo metabolic transformation in vivo, but it does exhibit a 
certain degree of lability at temperatures used in meat processing. The determination of 
the rate of OTC breakdown under conditions commonly used in meat processing would 
allow the appropriate authorities to estimate with greater confidence the probable intake 
of this compound and its degradation compounds in the diet. 
To date, few reliable techques  for the separation and quantification of mixtures 
of OTC and its common degradation products exist. A reverse-phase liquid 
chromatographic technique was developed that successfblly quantified mixtures of OTC. 
4epioxytetracycline (4-epiOTC), a- and P-apooxytetracycline (a- and P-apoOTC) 
down to 40, 20, 50 and 140 nglml, respectively, at ambient temperature in less than 35 
minutes. A 0.1 M ammonium acetate buffer (pH 3.0)-acetonitrile-tetrahydrobran 
(72.5: 12.5: 15. v/v/v) mobile phase was found by means of the simplex method of solvent 
optimization to give excellent separation of the compounds. Solid-phase extraction 
(using RP Clg cartridges) of OTC from aqueous media and tissue gave overall recoveries 
greater than 90 and 70 %, respectively. Degradation compounds had much lower 
, 
recoveries, excluding their being monitored by the developed technique. 
Previous research on the degradation of OTC during processing has focused on 
absolute changes in OTC. There have been no systematic studies on the rate of OTC 
degradation. The rate of OTC degradation was observed at 60, 70 and 80°C in several 
different aqueous a d  tissue media in order to ascertain the effects of the main factors 
commonly manipulated in meat processing practices (temperature, a,. pH, additives). In 
contrast to observations for other compounds, OTC degradation (as measured by k,h) 
was found to be independent of glycerol-adjusted water activities (a,) in the range 0.6 to 
1.0: entropy decreased as a, was lowered. Monomeric (ortho) phosphate significantly 
increased kob whereas polymeric phosphates significantly decreased (p < 0.05) $*. The 
addition of calcium chloride to aqueous solutions significantly lowered &*, and 
decreased the entropy of the reaction, due to the formation of thermally stable OTC-~a'- 
complexes. Sodium chloride and sodium nitrite were found to have negligible effects 
upon kbs in solution. 
When studying OTC degradation in tissue matrices, several unusual anomalies 
were evident. Degradation of OTC in porcine tissue was significantly lower than that in 
aqueous buffer. Addition of metal-chelating agents (EDTA, polymeric phosphates) 
increased Lb. to values similar to that observed in aqueous solution. This was speculated 
to be due to decreasing the availability of polyvalent cations for OTC complexation. 
which decreased the formation of OTC-cation complexes. Additional evidence for the 
occurrence of metal complexation was provided by binding studies of OTC to BSA and 
porcine tissue. The studies revealed that OTC binding to tissue was due in pan to 
complexing protein-bound ions. 
In contrast to observations in aqueous solution, sodium chloride and sodium 
nitrite in tissue increased bb. at 60°C, whereas k,,h was lowered at 80'~. Sodium nitrite 
in tissue had a dramatically greater effect upon k,+,, than aqueous sodium nitrite. Calcium 
chloride decreased ibb. in tissue, but to a much lesser extent than in aqueous solution. 
The formation of several degradation compounds was noted. Application of the 
biexponential model to quantify the formation of one unknown compound was not 
successfbl, indicating that its formation kinetics did not obey a simple first-order model. 
Enthalpy/entropy compensation was exhibited by all treatments, indicating that common 
meat processing practices do not change the nature of the rate-limiting degradation 
mechanism which according to previous literature and data obtained is an acid-catalyzed 
E2 elimination. 
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1. INTRODUCTION 
The world's population is increasing at an exponential rate. As a result, there is 
continuous pressure on available food resources to yield higher quantities with decreased 
inputs. This is accomplished by several means including mass production. selective 
breeding for favourable agronomic traits. utilization of more efficient farming practices. 
application of biotechnology, and increased utilization of by-products. Efficient farming 
practices includes the practice of intensive animal production with animals confined to 
restricted areas for the purposes of feeding and management. This practice does allow 
for an increased outputhput ratio, but at a cost. The close quarters are conducive to 
the spreading of disease. as well as increasing general stress levels. These factors, when 
combined, result in increased mortality rates, and ironically, decreased production. To 
offset this. xenobiotics (i.e. foreign compounds) are commonly used for the purposes of 
disease treatment, disease prophylaxis. and growth promotion. The range and number of 
xenobiorics allowed for use is vast, but the antibiotic class is the largest (MacNeii and 
Ellis, 1995). Antibiotics can treat or prevent disease by actively destroying 
microorganisms, or by severely limiting their ability to reproduce. 
Oxytetracycline, a member of the tetracycline family of antibiotics, is one of the 
most commonly used antibiotics in animal husbandry. It is bacteriostatic in nature. and 
has applications in active disease treatment, prophylaxis, as well as growth promotant 
properties. Health Canada regulates OTC usage in terms of amount, species. withdrawal 
times, and the maximum residue level (MRL) allowable in edible tissues through 
application of the Food and Drugs Acts and Regulations (Canada, 1985). Actual 
enforcement is the responsibility of veterinary meat inspectors at sanctioned meat 
processing facilities, as well as laboratory services provided by the Canadian Food 
Inspection Agency. Compliance with the regulations is generally good; however. the 
1994- 1995 Report on Chemical Residues in Meat and Poultry Products (.Agriculture and 
Agri-Food Canada, 1995) indicates that violative occurrences with OTC are increasing in 
swine. 
Because of the potential for OTC as wen as other xenobiotic residues in food 
products. there is some concern with adverse health effects as a result of exposure to 
them. OTC is generally not known for its ability to cause acute reactions upon exposure, 
though it has been reponed to occur. Better known are the adverse effects caused by 
exposure to degradation compounds of the tetracyclines. Degraded tetracycline 
preparations have been associated with reversible Fanconi syndrome. a form of kidney 
disease (Frimpter et al.. 1963). This has been attributed specifically to the presence of 
anhydrotetracycline in old formulations. Heat-degraded OTC has also been shown to 
exhibit toxic effects, though identification of the compounds responsible for ths has not 
been done (Tropilo et a].. 1988). 
Meat processing is the physical, chemical or enzymatic treatment of meat for the 
purpose of altering its original form. Processing serves the purposes of enhancing shelf- 
life. palatability, utility, and consumer preferences of a product. Thermal treatment of 
meat is a near ubiquitous process. Chemical treatments. such as the application of 
sodium chloride, phosphates. and sodium nitrite are also commonly used in meat 
processing. Each of these additives serve a different purpose during the conversion of 
raw muscle tissue to edible meat products, due to their unique chemistries. 
To date, there exists only limited information concerning the behaviour of OTC 
residues in tissue as a result of its exposure to common meat processing practices. 
Research to date has been limited to measuring the absolute changes in OTC amount as a 
hnction of a specific process, which makes extrapolation to other processing situations 
difficult. A better approach would be to determine the rate at which the amount of OTC 
changes as a function of processing parameters. This would allow for extrapolation of 
experimentally-derived results to other processes. 
The primary goals of this project were to determine and quantify the effects of 
common processing parameters (heat; water activity; the presence of sodium chloride, 
calcium chloride or sodium nitrite) upon the degradation of OTC. The first objective 
was to develop a method that was capable of detecting and quantitjing OTC as well as 
some of its common degradation compounds. Secondly, monitoring of Of C 
degradation as a function of time was required to quantify the rate of OTC degradation. 
as well as the rate of formation of degradation compounds. Thirdly, quantification of 
secondary kinetic parameters (energy of activation, changes in enthalpy and entropy) was 
performed to provide evidence for the interaction between processing parameters and 
OTC with respect to its rate of degradation. Fourthly, partitioning the effects of the 
processing parameter and the medium in which the degradation occurred (i-e. aqueous 
vs. tissue) was camed out to discriminate between processing and medium effects. As 
violative occurrences of OTC residues in pork tissue appear to be increasing (Agriculture 
and Agri-Food Canada, 1995). it was selected as the tissue for study. 
2. LITERATURE REVIEW 
2.1 Oxytetracycline 
2.1.1 History 
Antibiotics are a diverse may of chemical compounds that exhibit bacteriostatic 
and bacteriocidic properties towards susceptible microorganisms. Formal studies of the 
properties of antibiotics have been performed since the late nineteenth century (Rolinson, 
1995). In 193 5, sulphonarnides, a family of related chemical agents, were the first 
antibiotics utilized successfilly for the in vzvo treatment of bacterial induced infections 
which also exhibited minimal toxicity towards a eucaryotic host (Fleming, 1995). To 
date, several hundred different antibiotics are characterized with regards to their 
chemical and therapeutic properties. 
In 1949, chlortetracycline (CTC) was the first antibiotic of the tetracycline family 
isolated (Mtscher, 1978). Oxytetracycline (OTC) was isolated from the fermentation 
liquors of Strepomyces r imom in 1949 at Pfizer Laboratories (Mtscher. 1978). The 
formal chemical abstracts indexing name for OTC (Figure 2.1) is 2- 
nap hthacenecarboxarnide, C(dimethylamino)- 1, 4, ?a 5. 5 a. 6. 1 1, 12a-octahydro-3. 5 .  
6. 10, 12. 1 2a-hexahydroxy-&methyl- 1, 1 1 -dioxo, 4s-4a, 3aa. 5a. 5aa. 6P, 12aa. The 
chemical abstracts service (CAS) registry number is 79-57-2. Tetracycline. a 5- 
dehydroxy form of OTC. is the parent substance of the tetracycline family of antibiotics 
for nomenclatural purposes. 
4-epi oxytetracycline 
a-apooxytetracycline 
Figure 2.1. Structure of oxytetracycline and related degradation compounds. 
2.1.2. Biosynthesis 
Tetracyclines are secondary, polyketide-derived metabolites of actinomycetes, 
primarily Srrepfomyces aureofaciens and S. rimoms microorganisms. Polyketide and 
fatty acid biosynthesis involve head-to-tail condensation of acyl compounds, and thus 
both biosynthetic routes share some common reactions. The common reactions for the 
synthesis of both compounds involve acetyl, acyl and malonyl transferases, and 
P-ketoacyl synthase (Vining and Hopwood. 1995). The biosynthetic pathways diverge 
after creation of a P-ketoacyl intermediate; fatty acid biosynthesis involves subsequent 
reduction and dehydration reactions to generate fully reduced acyl groups, whereas 
additional acetyl groups are attached to the P-ketoacyl intermediate in polyketide 
synthesis. 
The skeleton of all tetracyclines are synthesized from one malonic acid semiamide 
and eight malonyl-CoA units by monofhctional proteins that associate to form a multi- 
enzyme complex. The first intermediate in the biosynthesis of OTC is 6- 
methylpretetramid (Figure 2.2). Subsequent reactions include hydroxylation at C-4. 
hydration at C- 12% transamination and N-methylation at C-4, hydroxylation at C-6 and 
C-5, and reduction of the C-5a, C- 1 la double bond (Behal and Hunter, 1995). 
2.1.3 Chemical Reactivity 
Oxytetracycline is chemically stable in dry form or in aqueous solution if kept at 
refrigeration or subrefrigeration temperatures (Honikel et al., 1978; Iversen et al., 1989). 
However, at higher temperatures it becomes increasingly labile. Cinder mildly acidic or 
basic conditions, the degradation kinetics are dictated primarily by the C-5 and C-6 

hydroxyl moieties, and the C-4 dimethylamino group (Mitscher, 1978). The C-6 
hydroxyl is axial and trans to the CSa-H, making it sterically ideal for an E2 elimination 
reaction (Figure 2.3). The resultant anhydrooxytetracycline formed can be isolated in 
alkali media, though it is otherwise unstable, and undergoes scission of the B ring 
(mediated by the C-5 OH group) to produce the isomeric phthalides, a- and P- 
apooxytetracycline (a- and P-apoOTC) (Yasin and Jefies, 1988). OTC undergoes 
first-order reversible epimerization of the C-4 dimethylamino group in a variety of 
aqueous solvents within the pH range of approximately 2-6 (McCormick et al., 1957); 
the rate of epimerization is dependent upon the nature of the ions present in the reaction 
media. 
The toxicological significance of OTC thermal degradation products has been 
reported (Tropilo et al., 1988) though the chemical nature and quantity of the 
degradation compounds were not determined. It has been shown that 
epianhydrotetracycline, a degradation product of tetracycline, can cause nephropathy in 
susceptible individuals (Frimpter et al., 1963; Wegienka et al., 1964; Cleveland et al.. 
1965: Fulop and Drapkin 1965). 
Tetracyclines are strong metal chelating agents, with the site of chelation due to 
the 1 1, I2-P-dicarbonyl system and the A ring. At low p K  chelation occurs at the BCD 
rings and as the pH is increased, the A ring becomes invoiced with the carboxarnide 
group and the 1 or 3-enol. Equilibrium constants &) for the chelates of multivalent 
positive ions with OTC range from log values of 4 to 9 (Albert. 1953). 
OTC 
OH 
a and P-apo-OTC 
CONH-, 
OH OH 0 OH 
Figure 2.3. Degradation of oxytetracycline by C-5a: C-6 E2 elimination. 
OTC also undergoes complexation with several unrelated classes of biochemicals 
(Higuchi and Bolton, 1959), as well as with ions. Equilibrium constants ranging from 2 
to 30 have been reported for several biochemicals (Higuchi and Bolton, 1959). The 
interaction of tryptophan with OTC has a reported K, of 4. Human and bovine serum 
albumin (BSA) have been reported to complex with OTC with K, of log value 4 (Ma et 
al., 1973; Zia and Price, 1976). However, equilibrium constants are a function of both 
the method of determination, as well as protein concentration. It is known, however. 
that the predominant mechanism for OTC binding to protein is hydrophobic in nature, 
with bonding occurring at or near tryptophan residues. Other mechanisms, such as 
charge-transfer, hydrogen bonding and ionic interactions also influence the extent of 
interaction. 
2.1.4 Analysis 
Analysis for antibiotic residues in animal tissues has traditionally been performed 
using bioassay techniques. These techniques include diffusion systems (cylinder-plate. 
well-plate, pad-plate), turbidimetric systems. and immunological systems (Nelis and 
Leenheer. 1980; Hasselberger. 1993). Diffusion assays are capable of detecting 80- 100 
ppb OTC in animal tissue. However, tetracyclines have a high affinity for the tissue 
matrix (this has been attributed to hydrophobic binding and charge transfer mechanisms), 
thereby making difision assays inaccurate; lipophilic derivatives of tetracycline are 
particularly prone to this problem (Nelis and Leenheer, 1980). The official AOAC 
method 968.50 (Association of Official Analytical Chemists. 1990) is a non-specific 
micro biological plate assay (Hasselberger, 1 993). Other assays such as the swab test on 
premises (STOP) lacks sensitivity and specificity for detection of OTC residues (MacNeil 
et al., 1989). 
HPLC methods have gained prominence for the analysis of OTC. The limit of 
detection for OTC residues using ultraviolet detectors is reported to be approximately 10 
ppb (White et id., 1993). Reversed-phase chromatography is the preferred method for 
OTC analysis (Oka and Suzuki, 1984), though the exact nature of the separation 
mechanism is still unknown. Adjustment of the mobile phase pH alters the ionic form of 
the tetracyclines; at low pH. the cationic form of tetracyclines are predominant, so that 
interactions with negative counterions are then favoured (Knox and lurand, 1975). 
However, increasing the ionic strength decreases the chromatographic capacity of 
tetracyclines. which conflicts with retention behaviour based solely on hydrophobic 
interactions. It is assumed that solutes in the mobile phase adsorb onto the packing, 
displacing the tetracyclines from the active sites. Mobile phases containing phosphate 
buffers give chromatographic efficiencies and capacities similar to those containing 
organic acids. These findings indicate that interaction of tetracyclines with Free silanol 
groups of the silica support are in part responsible for the separation mechanism. 
Polymeric columns.are also used for separation work on tetracyclines (Naidong 
et al., 1990; Agasoster and Rasmussen, 1992; White et al., 1993). Polymeric columns 
avoid problems of interaction of tetracyclines with the free hydroxyl groups of the silica 
support of alkyl bonded columns and of reduced column lifetime due to the use of acidic 
mobile phases that are sometimes used for tetracycline analysis (Reeuwijk and Tjaden. 
1986; Naidong et al.. 1992). It is believed that the separation mechanism of tetracyclines 
on bare polystyrenedivinylbenzene (PSDVB) supports is due to K-n interactions 
between the D ring of the tetracycline and the aromatic rings of the stationary phase 
(Naidong et al., 1990). It has been stated that the column efficiencies of polymeric and 
dkyl-bonded columns of similar particle sizes are similar, though some researchers have 
stated that resolution of PSDVB columns is poor in comparison to alkyl-bonded columns 
(Salisbury, 1993). PSDVB columns have the advantage of separating epimers of the 
tetracyclines; alkyl-bonded columns apparently lack this ability (Khan et al, 1987; Yasin 
and Jefies, 1988; Naidong et al., 1990). However, other reports (Hoogmartens et al,, 
1989) indicate the resolution of doxycycline and its epirners on reversed-phase columns; 
Barnes et al. (1 985) success~lly separated a mixture of OTC, a-apoOTC, P-apoOTC 
and anhydroOTC on an octyl-bonded column, with CepiOTC being partially resolved 
fiom OTC. 
A method that has been used at the Health of Animals Laboratory (Canadian 
Food Inspection Agency, Saskatoon, SK) is based on the method of Oka et al. ( 1985). 
E.xtraction of the cationic species of tetracyclines from tissue is accomplished using an 
aqueous pH 4.0 EDTA buffer. Solid-phase extraction (SPE) C l 8  cartridges (Bond Elut 
C l g )  are used to clean the extract by non-specifically binding drugs fiom the aqueous 
extract. Bond Elut C18 cartridges are preferred over Sep-Pak C18 and Baker 10 Cia 
cartridges due to superior adsorption capacities for tetracyclines (Oka et al.. 1985). SPE 
cartridge consistency is vital for reproducibility. Carignan et al (1993) utilized a sample 
preparation procedure omitting the use of SPE to decrease variability in results; when 
tissue was spiked at 1 ppm, a day to day coefficient of variation (CV) of 13 % was 
obtained. The method of Oka et al. (1985) reported a CV less than 10 ?&. Oka et al. 
( 1 987) used tandem reversed-phase and ion-exchange cartridges for cleaning honey 
samples for residue analysis; this was not found to be necessary for tissue samples. 
Mulders and Van de Lagemaat (1989) found that treating Sep-Pak Cis cartridges with a 
solution of 4 % dimethylchlorosilane prior to activation eliminated residual silanol 
groups; the resulting recoveries of OTC increased fiom 80 to 100 %. Drug elution from 
the columns is accomplished using a methanolic oxaiic acid solution. This precludes the 
ability to concentrate the solution due to the decomposition of the tetracyclines by oxalic 
acid during evaporation (Ikai et al., 1987; Mulders and Van de Lageemaat, 1989). The 
tetracyclines are chromatographed on an hensilB reversed-phase Cs column. hertsil"' 
columns have been end-capped to reduce the number of kee silanol groups present, 
thereby decreasing polar interaction of tetracyclines with the support, subsequently 
reducing tailing and increasing resolution. A C8 column has been used for the separation 
of tetracycline from its degradation products (4-epitetracycline, anhydrotetracycline and 
4-epianhydrotetracycline) (Oka and Suzuki. 1984) and for the partial separation of OTC 
from 4 epi-OTC, a-apoOTC, P-apoOTC and anhydroOTC (Barnes et al.. 1985). 
Iversen and coworkers ( 1989) reported that reversed-phase columns could not be used 
for the analysis of OTC residues in plasma of rainbow trout due to endogenous 
compounds coeluting with OTC. Instead, a cyano column was used to give good 
results. This is in contrast to the results of Bjorklund (1988) who reported using Cs and 
C columns successfLlly for analyzing OTC from rainbow trout. Bjorklund ( 1988), 
however, used an SPE cartridge for isolation of the tetracyclines, whereas Iversen and 
coworkers (1 989) did not. Ueno et al. (1992) describe a direct injection technique of 
rainbow trout serum spiked with OTC on a HISEP shielded hydrophobic phase column 
(polymer hydrophilic/hydrophobic phase bonded on silica gel). 
The use of electrically driven separation methods (i.e. capillary electrophoresis. 
(CE)) for the separation of tetracyclines has been explored only recently. Impediments 
to the incorporation of such methods for the analysis of drug residues are primarily due 
to the dficulty in detecting low concentrations of material because of the relatively small 
sample sizes (nl vs pl in HPLC) used. This can be circumvented by sample concentration 
techniques, and research has shown that CE can be used successfully to separate 
different tetracycline mixtures (Chen and Gu, 1995; Pesek and Matyska, 1 996). 
However due to the use of concentration steps, reproducibility does decrease. 
Additionally, no CE technique to date has been reported that is capable of separating the 
common OTC degradation products. 
2.2- Biological Properties of Oxytetracycline 
2.2.1 MedicaYAgricultural Uses 
Chopra (1 985) reported that the major mode of the tetracyclines' inhibitory 
action upon bacterial growth is their ability to bind with a relative high affinity 
(log K, z 6) to the ribosomal A-site, thereby interfering with the binding of arninoacyl 
tRNA's to ribosomes which interferes with protein synthesis. At higher concentrations. 
binding to the ribosome P-site as well as inhibition of polypeptide chain termination also 
occur. Therefore, transport of tetracycline into the cell is a prerequisite for its 
bioactivity. Transport into the cell is dependent upon the type of bacteria. Gram- 
negative bacteria have an outer membrane in addition to the cytoplasmic membrane 
found in gram-positive bacteria. Transport of tetracyclines across this outer membrane is 
by means of passive diffusion through transmembrane protein pores and apolar 
membrane regions. OTC, due to its relatively polar nature (water solubility. 5-3 1 
rng/ml), diffuses primarily through the hydrophilic protein pores (Chopra, 198 5 ) .  
Transport of tetracyclines across the cytoplasmic membrane is by both passive diffusion 
as well as energy dependent systems. The primary energy dependent system involved is 
the carrier mediated transport system coupled to the proton motive force. Tetracycline 
resistance is due primarily to the ability of the organism to actively remove tetracyclines 
from the cytosol of the organism via other carrier mediated transport systems. 
Tetracycline antibiotics are broad-spectrum antibiotics, effective against a wide 
range of microorganisms. Microorganisms of the genera Staphylococcus, Sirep~ococncs, 
Legionella, Chlamydia, Pastewella and Mycopiastna are generally sensitive to all 
members of the tetracycline family (minimum inhibitory concentrations 0.04-3.1 pg/ml) 
(Cunha, 1985). In addition to medical uses, however, tetracyclines are popular for use in 
veterinary formulas that are both active and prophylactic in nature (Gustafson and Kiser. 
1985). As a result, the use of tetracyclines and other antibiotics for veterinary uses 
accounts for approximately half of all antibiotics produced. with a majority of this due 
primarily to use as feed additives (Shahani and Whalen 1986). 
The major prophylactic use of the tetracyclines is for their inter-related properties 
of growth promotion and disease prevention. It has been shown that antibiotic use at 
subtherapeutic levels results in reduced mortality, increased weight gains, lower feed to 
gain ratios, which results in lower production costs and hence increased returns on profit 
(Hays, 1986). 
2 2 . 2  Regulatory Overview of Veterinary Drugs 
In Canada, the registration and approval of veterinary drug products is carried 
out by the Bureau of Veterinary Drugs. Health Protection Branch by way of the Food 
and Dnigs Acts and Regulations (MacNeil and Ellis, 1995). a process which 
approximately parallels that in the United States. To get approval, a sponsor must 
supply data with regards to the drug's clinicai uses as well as its target species. human 
safety assessment, and procedures for analysis of the active ingredient in formulations as 
well as for analysis of residues in edible tissues at the established MRL. Human safety 
data includes information regarding metabolic studies of the drug in the target species, 
the form (metabolite) in which potential residues are found, and their distribution in the 
animal. Toxicity/carcinogenicity data, another component of the human safety data, is 
collected to establish an acceptable exposure level to the drug/metabolites. In Canada. 
there is not an established MRL for OTC, though for tetracycline the level is 0.25 mgikg 
(0.25 ppm) for most edible tissues and fluids (MacNeil and Ellis, 1995). 
Residue monitoring is the responsibility of the Canadian Food Inspection Agency 
(Canadian Food Inspection Agency, 1997). Both random monitoring, based on a 
national survey plan. and suspect monitoring is conducted by veterinary meat inspectors 
at slaughter plants. Suspect monitoring refers to analysis of animals with obvious lesions 
or that are of questionable health at the time of slaughter. Though compliance with 
residue levels is generally good. pork violative rates have been increasing. Levels of 
OTC that have been found in pork muscle tissue have been as high as 1.74 ppm. whereas 
hog kidneys have had levels up to 2 I .  1 ppm. well in excess of acceptable residue levels 
(Agriculture and Agri-Food Canada, 1995). 
2.2.3 Phannacokinetics 
2.2.3.1 Animal Species 
The 1993 Canadian Compendium of Veterinary Products (Canadian Animal 
Health Institute. 1993) lists several injectable formulations meant for use in cattle, swine, 
and sheep. Additionally, several species of scientific and economic importance have also 
been tested for their internal distribution and disposition of OTC. including mice (Snell, 
et al.. 1958)- rats (Curl et al., 1988), horses (Horspool and Mckellar, 1990), rabbits 
(McElroy et aI., 1987)- buffalo (Varma and Paul, l983), camels (Oukessou et al.. 1992). 
turkeys (Dyer. 1989)- and various farmed fish species (Bjorklund and Bylund, 199 1). 
Pharmacokinetic parameters including half-lives (tin) and volumes of distribution (VJ) 
have been calculated for these animals. Half-life indicates the time needed for the 
concentration of drug to reduce to one-half of its initial measured concentration; V d  is a 
measure of the distribution of the drug throughout the body, defined as the ratio of dose 
administered to the initial plasma concentration. Hence, a low Vd indicates that the drug 
is confined primarily to the circulatory system, whereas a high V d  indicates that the drug 
is distributed to other tissues of the body (Shargel and Yu, 1993). Table 2.1 summarizes 
these parameters for adult animals of economic importance. Kirkwood and Widdowson 
( 1990) report that the elimination half-life of OTC can be modelled as a hnction of 
bodyweight by an allometric equation. Utilizing literature data, they were able to fit half- 
life data according to the allometric equation: 
tl,z(final elimination phase) = 160w'.~' 
where w is  the weight of the animal. This equation was found to be not significantly 
Table 2.1. Half-lives (tm) and volumes of distribution (Vd) of intravenously 
administered oxytetracycline formulations in different animal species. 
Species/Animal t (min) Vaarea(L/kg) Source: 
Cow 540-6 18 0.80-0.87 Nouws et al., 1983 
Toutain and Raynaud, 1983 
Pig 225-306 1.38-1-84 Xia et al., 1983 
Pipers et al., 1990 
Sheep 22 1 --- Kirkwood and Widdowson, 1990 
Camels 460 0.80 Oukessou et al., 1992 
Rabbit 54- 120 0.55-1 -37 McElroy et al., 1987 
Turkey 43 3 -60 Dyer, 1989 
Rainbow Trout 4800 1.33 GrondeI et al., 1989 
different from the allometric equation describing metabolic turnover time. This 
relationship was determined using a database of terrestrial homeotherms including the 
cow, pig, camel, buffalo, sheep, goat, rabbit, pheasant, chicken and turkey. From 
Table 2.1, it is evident that this equation does not apply to aquatic life, as OTC 
elimination is also dependent on environmental temperature (Grondel et al., 1989; 
Bjorklund and Bylund, 199 1). Similar correlations have not been determined for Va, 
though differences have been noted for other pharmacokinetic parameters. Banting et al. 
(1985) reported that the area under the curve (AUC- a measure of drug availability) for 
the same dosage levels applied to calves and pigs were 2.6 times lower in pigs than 
calves. This in turn indicates that dosage levels would have to be substantially higher in 
swine than in calves to maintain equivalent therapeutic levels. 
2 - 2 - 3 2  Tissue Type 
Early reports on the pharmacokinetics of intravenously (iv) administered OTC 
indicated that the elimination of OTC was primarily by excretion via glornemlar filtration 
(Kunin. 1 967). Mevius et al. ( 1 986a) had reported that in swine only 12-60 % of iv 
doses are eliminated renally, and that this clearance was urine flow dependent. and 
correlated well with creatinine clearance, indicating that OTC was excreted by 
glornerular filtration and tubular secretion. A similar mechanism was reported in dairy 
cows (Mevius et al., 1986b). The remainder of the dose is speculated to be eliminated 
by fecal excretion via losses incurred during enterohepatic recycling, and sequestration 
by bones. The effect of sequestration was speculated to be of significance since OTC 
sequestration would be greater in young, growing animals, thereby resulting in 
potentially longer persistence of the dnig in the animal. 
The kinetic model of elimination of OTC has been controversial, due to different 
investigators using different assay procedures, dosage levels, and type of 
pharmacokinetic analyses (Banting et al., 1985). Both two and three compartment open 
models have been applied to pigs and cows (Xia et al., 1983); differences in conclusions 
have been speculated to be due mainly to the frequency in which initial blood sampling is 
performed. A large number of samples in the initial phases suppons the three 
compartment model (Figure 2.4). The ratio of back diffusion to the central compartment 
for compartments 2 and 3 for cows and pigs is approximately 10, indicating that the 
elimination of OTC fYom the deep tissue compartment is significantly slower than from 
the secondary tissue storage compartment. The deep tissue compartment has been 
speculated to be the result of enterohepatic recycling or bone storage (Meijer et al.. 
1993). A graph of a typical plasma concentration-time curve for an iv administered dose 
of Of C is illustrated in Figure 2.5. 
Intramuscular (im) administration of OTC has the advantage of maintaining 
therapeutic levels of OTC in an animal for extended time periods with only minimal 
animal handling. Rate of absorption of the drug from the depot site (k,) has been 
speculated to be due to two factors; difision of the drug into the bloodstream and blood 
flow to the depot site (Bederka et al., 1971). If diffusion was the rate-limiting step for 
drug absorption from the depot site, it would be proportional to the concentration and 
would proceed by means of first-order absorption (Greenblatt and Koch-Weser. 1976). 
The primary determinant for k, would be the drug partition coefficient. Lipophilic drugs 
* 
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Figure 2.4. Schematic diagram of the three compartment open model. 
Peripheral compartment 2 = tissue storage; 
Peripheral compartment 3 = deep tissue storage; 
Source: Mevius et al. (1986b). 
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Figure 2.5. Measured concentrations (mean) and mean fitted plasma concentration 
time curve for oxytetracycline after a single iv administration of 40 m a g  
body weight to veal calves (n=5). 
Source: Adapted from Meijer et al. ( 1  993). 
would diffuse directly through the membranes of capillary endothelial cells into 
circulation, whereas hydrophilic drugs can enter circulation only via the pores in the 
capillary membrane (Chopra, 1985). Lymph flow would only account for a small 
fraction of the drug removed From the injection site. However, for OTC, diffusion from 
the injection site is normally not the rate-limiting step. Nouws and Vree (1983) 
compared the absorption of irn administered OTC preparations as a function of injection 
site; neck. shoulders, buttocks or subcutaneous injection (neck). Injection in the buttock 
region resulted in the lowest absorption and degree of bioavailability (83 %) for the 
formulation; the shoulder injection had a significantly higher bioavailability (99 O h )  as 
compared to an iv injection. 
Absorption from im injection sites normally does not follow fxrst-order kinetics, 
but is instead referred to as "non-linear absorption" (Greenblatt and Koch-Weser. 1976). 
This is due to several factors, including spreading of the injection volume to a larger area 
(thereby increasing ka), increased osmotic pressure at the site of the injection (thereby 
drawing water into the site of injection, decreasing ka). and drug precipitation at the 
injection site (decreasing k,). The most significant factor affecting k, is the amount of 
tissue damage at the injection site caused by the formulation (Mevius et al.. 1986a and b; 
Nouws et al.. 1990). The tissue damage itself has been attributed to both OTC and the 
delivery solvent (Rasmussen and Svendsen. 1976; Rasmussen, 1978). Tissue damage 
usually constitutes extensive oedema, fibro-angioblastic tissue, haemorrhages and muscle 
degeneration. Injection of OTC in aqueous solutions at concentrations less than 5 mg/ml 
has been reported to cause no visible tissue damage (Wright et al., 1954); however, the 
degree of reaction increases with increasing concentration. Polyvinyl pyrrolidone has 
been reported as causing only minimal tissue damage (Mevius et al., 1986b); other 
vehicles such as aqueous 2-pyrrolidone and glycerol fonnaldehyde have been reported to 
cause extensive damage at injection sites (Nouws et al., 1990). The greater the degree 
of irritation, the greater the amount of residues found at the injection site. Mevius et al. 
(1986a) had proposed that tissue irritation effects cause variable residual OTC amounts 
due to two sequential events; an initial decrease in k, due to a decrease in local blood 
circulation which in turn is due to initial tissue irritation, followed by an increase in blood 
flow and increasing k, due to tissue inflammation. Intramuscular administration of O K ,  
therefore, provides prolonged release of OTC though it can be unpredictable. A 
schematic model (Figure 2.6) illustrates this unpredictability. Two or more different kas 
are believed to exist, with the potential for a plasma concentration-time curve to exhibit 
both traditional and "flip-flop" kinetics during elimination. In traditional kinetics. k, is 
higher than kl, whereas "flip-flop" refers to the phenomena whereby k, is lower than CI. 
which affects the calculations required to estimate these parameters. The only way in 
which it can be verified that an im injection is exhibiting flip-flop kinetics is by 
comparison to an iv injected formulation. 
Drug disposition in the body has been shown to be affected by disease status 
(Ames et ai., 1983; Shargel and Yu, 1993). The two main mechanisms by which this 
occurs are the alteration of the elimination constant or alteration of storage 
compartments. These effects cannot be quantified due to inherent uncertainties in the 
disease process. 
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Figure 2.6 Open 3-compartment model with 2 compartments of absorption. 
Source: Adapted fkom Toutain and Raynaud (1983). 
2.3 Effect of Processing on Oxytetracycline Stability 
2.3.1 Meat Processing 
Meat processing is defined as any physical, chemical or enzymatic treatment of 
meat that alters its original form (Romans et al., 1994). Processing serves the purposes 
of enhancing shelf-life, palatability, utility, and consumer preferences for a product. 
Processed meats include comminuted (e.g. sausages, meat patties), non-comminuted 
(e .g .  ham, bacon), restmctured and canned products. The common non-meat ingredients 
used for meat processing are water, nitrite, cure colour accelerators, salt, phosphates, 
plant proteins and other water-binding agents, and sweeteners, which may or may not be 
used in conjunction with heating (Claus et al., 1994). Nitrite is used primarily to prevent 
the outgrowth of Ciosnidium b o t u l i m  spores and subsequent toxin production as well 
as for colour and flavour formation; its presence in cured products is limited to levels 
below 200 ppm (Canada, 1994). Cure accelerators increase the rate of cure as well as 
having antioxidant properties to maintain the overall quality of a product. Salt is used 
for flavour, extracting proteins (subsequent increase in functionality), and extending 
shelf-life by lowering the water activity (a,) of a product. Normal usage is 
approximately 2-3 % by weight of product. Phosphates are utilized for their ability to 
increase the water-holding capacity of meat as well as their antioxidant propenies. Their 
use is limited to 0.5 % (dibasic orthophosphate basis) of the fird weight of the product 
(Canada, 1994). 
Heating is a near ubiquitous mode of meat processing. In addition to inactivation 
of microbes and enzymes, it induces several other changes in meat products. At 40- 
50°C. sarcoplasrnic proteins begin to denature; at 50-65'C, myofibrillar proteins 
denature with a subsequent decrease in water binding capacity and increased pH. At 65- 
80°C. collagen also begins to undergo changes similar to the myofibrillar proteins (Van 
Laack, 1994). Also during heating, 60-70 % of added nitrite will be decomposed 
(Okayarna et al., 199 I), though it was reported that cooking time, and not temperature is 
more important in determining the rate of nitrite destruction. The reponed energy of 
activation (E,) for nitrite decomposition is 13- 14 kcallmol (Olsman, 1973), which 
supports Okayarna's and coworkers' findings. Polyphosphates are rapidly hydrolysed by 
in situ phosphatases present in meat (Moliis, 199 l), but these same enzymes are 
inactivated at temperatures greater than 60°C. Wazer and Cdlis (1 95 8) reported that at 
pH 5-6, the rate of temperature induced hydrolysis of phosphates is slow. 
The alteration of a* in foodstuffs is one of the main methods used for increasing 
the shelflife of a food product. Several definitions for a, exist. The first such expression 
was based on the escaping tendency of a solvent (also known as fugacity) from solution 
relative to that of pure solution. Later definitions used the approximation of the partial 
pressure of water above a solutionlmatrix relative to that of pure water (the two 
previous definitions tended to be within 1 % of each other, and are therefore regarded as 
being equal) (Fennema, 1985). By lowering a,, you are decreasing the availability of 
water for physical, chemical, biochemical and rnicrobiologicai reactions. As most 
reactions require the presence of a solvent media in which to occur, decreasing the 
availability of the solvent tends to decrease the rate of detiorative reactions. The a, of 
most processed meat products ranges from 1 .O to 0.6 (Leistner et d., 198 1). An a, of 
0.86 or lower prevents toxin production by Sfaphyflococnrs aurrrrs. one of the main 
pathogens of concern in meat products. 
Nitrite is a strong oxidizing agent W O 2  + H- + e + NO(g) + H20, E0 = 1.0 V). # 
It is by this reaction that the true curing agent, nitric oxide (NO), is formed which 
combines with myoglobin to form nitrosyl-hernochrome. Cure accelerators act as 
eiectron donors for the reaction, increasing the rate of the reaction. Nitrite also 
undergoes nitrosation reactions with proteins, and nitrosated products of tyrosine, 
tryptophan and phenylalanine have been isolated (Woolford et al.. 1976). 
Phosphates commonly used in meat processing are monomeric, dimeric, trimeric 
or formulations containing a mixture of varying degrees of polymerization (i.e. 
hexametaphosphate). They are used as antioxidants as well as to increase the water 
binding properties of cooked meats, the mechanism by which this occurs believed to be 
primarily a pH increasing effect, though evidence for actomyosin dissociation and 
myofibrillar protein dispersion exists (Lewis et al., 1986). 
2.3 2 Stability Testing of Pharmaceutical Formulations 
2.3 2 . 1  Methodology 
Pharmaceutical stability has traditionally referred to the chemical stability of a 
drug substance in its dosage form (Carstensen, 1995). This is studied through the use of 
chemical kinetics, whereby the drug in a pure system or one including as few adjuvants 
as possible is evaluated to determine the manner and rate of degradative reaction 
mechanisms. This in turn allows for the determination of the stability of the formulation, 
which is of importance when establishing expiration dates. Stability tests on 
formulations are performed throughout the entire drug dosage development sequence. 
In the USA as well as in Canada, the general overall sequence as reported by Carstensen 
( 1995) is as follows: 
a) S ynthesidextraction of a series of promising bioaaive compounds, based on 
theory or previously studied compounds of similar chemical structure. 
b) Pharmacological evaluation of the series. 
C) Selection of promising members of the series for hrther studies. 
d) Small scale synthesis of promising compounds. 
e) Toxicological investigations (chronic, acute) of formulations. 
f) Large batch synthesis. 
g) Phase I clinical testing (pharmacology in humans). 
h) Phase II clinical testing (dose-level response investigations. side effects. 
bioavailability). 
i) Phase I11 clinical testing (large scale). 
j) Full production. 
1 ) first production lots. 
2) routine production. 
3) formula change. 
Stability studies of the drugs serve different purposes throughout the new drug 
development procedure. Stability studies during toxicological evaluations ascenain the 
purity of the preparations being studied, as well as evaluate the toxicological potential of 
degradation compounds. The primary purpose of drug formulation is to create a suitable 
delivery vehicle which is also stable. Full production can introduce unknown variables 
that affect drug stability, and stability testing during this phase is used to ascertain what 
effect these unknown variables have on the formulation stability, and what the likely 
expiration date should be for the formulas. Quality assurance programs are carried out 
on a routine basis to assure stability of the drug production process. 
Chemical kinetics is defined as the study of the rate of changing proportions of 
reactants and products (Carstensen, 1995). The rate of change can generally be 
classified by the order of reaction. Reaction order refers to the dependence of the 
reaction upon reactant/product concentration. A zero-order reaction proceeds at a rate 
independent of reactant concentration; a first-order reaction is dependent on the 
concentration of one reactant; and a second-order reaction is dependent on the 
concentration of two reactants or on the squared concentration of one reactant. These 
reaction orders and their differential and integrated forms are summarized in Table 2.2.  
OTC degradation is a second-order reaction, dependent upon the concentration of OTC 
and water ( C o ~ o r s  et al., 1986). However, in solution, the concentration of water is 
extremely large (- 55.5 M) relative to that of OTC concentrations normally encountered 
in pharmaceutical preparations or as meat residues; therefore. the degradation rate of 
OTC is effectively dependent upon the OTC concentration only (Comors et al.. 1986); 
this reaction is referred to as a pseudo-first-order reaction. 
Determination of the order of reaction may be accomplished via the van? Hoff 
method (Swinboume, 1971). Briefly, both sides of the differential equation are 
transformed by a in function. Solving for the unknown in the resulting equation gives 
the order of the reaction: 
In(- d[Al) = Ink + 11 ln[A] dt 
Table 2.2. Differential and integrated form expressions for different orders of rate 
reactions. 
Order Differential Form Integrated Form Units of the 
rate Constant 
0 44 [A]. - [A] = M t" 
--=k 
whereby n is the order of the reaction. These orders can be determined with respect to 
time (i.e. changes in concentration of the reactant during the course of the reaction) or 
with respect to concentration (i-e. changing initial concentrations of the reactant for 
several different experiments, and determine the immediate change in concentration). 
Determination of the order of reaction with respect to concentration is considered to 
give a true indication of the order of the reaction, as only initial changes in reactant 
concentration are measured, and subsequent product formation is only minimal. This 
prevents the formation of potential inhibitory or catalytic products which may alter the 
rate of further parent compound degradation. Linear regression of the appropriate 
integrated form of the equation can give estimates of the desired parameters. 
Calculation of degradation rate constants can be accomplished by fitting the 
natural log transform of the concentration data to a linear model with respect to time. 
This is a standard integral method for the determination of such constants (Carstensen. 
1995). 
Chemical stability testing of pharmaceutical formulations is determined under 
several temperature regimes; these generally include the recommended storage 
temperature for the drug product, a lower than recommended temperature if the 
formulation is temperature sensitive, and a higher than recommended temperature 
(usually l S0C higher than recommended storage temperature) for accelerated testing 
purposes (Carstensen, 1995). Accelerated testing data can be utilized to determine the 
impact that excursions beyond the recommended storage conditions may have upon drug 
stability. This is accomplished by utilizing the rate constants obtained at the different 
temperatures to determine the energy of activation (E,) values. The E, gives an 
indication of the "ease" with which a reaction can occur, and is determined by plotting 
the In k,,h of the reaction rates as a hnction of 1/T(K). Two common theories of 
reaction rates exist; the collision theory and the absolute rate (transition state) theory 
(Chang, 198 1). The collision theory is based on the kinetic theory of gases, in that the 
rate of a reaction can essentially be calculated if the physical size and mass of the 
reacting moiecule, as well as the temperature, are known. The theory then allows for the 
calculation of the number of collisions occumng between reactants which then leads to 
the formation of products. However, two additional factors have to be considered. 
First. the steric factor must be accounted for, which refers to the requirement for the 
reactants to be properly oriented with respect to each other for a productive reaction to 
occur (i-e. entropy). Secondly, the frequency factor is required, which refers to the 
number of coUisions occurring that are productive (i.e. E,). The bases for calculating 
these factors is rooted in quantum mechanics. making the collision theory impractical to 
use. The transition state theory is favoured as it allows for the analysis of the energetic 
and entropic components of a reaction process (Carey and Sundberg, 1990). Briefly, the 
theory assumes that a reactant must reach a high energy, activated state before forming 
the product. Attainment of the activated (transition) state is the slowest, and therefore 
rate determining step of the reaction. This can then be treated as an equilibrium reaction: 
A+A* (activated comp tex) [?.I] 
The rate of decomposition of an activated complex is given as: 
kkT 
rate (k,) = - 
h 
where k = the transmission coefficient (generally taken as I), k is BoltzmannTs constant 
(1.3805 x 10-16 erg K') and h is Planck's constant (6.6256 x erg s). The unit for 
the expression then becomes s-' (a first order rate constant). However. From the 
following thermodynamic relations 
AG* = M* -TAS* [3 51 
AG* = -RT In K* [2 .6]  
The following relationship between rate of reaction and temperature can be derived: 
kkT 
rate (kJ = - (e~m''RT)(es'a) [2.7] h 
whereby H and S are the enthalpy and entropy of activation, respectively. A linear plot 
of In ratem as a function of 1/T gives a slope of -AH*/R. The change in entropy (AS) 
can be determined by the relationship: 
AH* hkr AS = -+ Rln- 
T kT 
In solution, enthalpy and entropy of activation reflect both the reacting species molecular 
changes and the reaction medium's effect upon the formation of the activated complex 
(Carey and Sundberg, 1990). Negative values of AH indicate a decrease in the energy 
content of activated complex due to breaking of bonds. Negative values of AS indicate a 
decrease in the entropy of the activated state. which corresponds to increased restrictions 
on movement. These increased restrictions can be due to formation of a more structured 
activated complex or due to increased ordering of the medium surrounding the complex. 
Positive values of AS indicate an increase in the entropy of the activated state, which 
corresponds to decreased restrictions on movement. This can be due to formation of a 
less structured activated complex, or decreased ordering of the medium surrounding the 
complex. 
2.3 -2.2 Statistical Evaluation 
Statistical evaluation of the parameters governing chemical stability kinetics is 
essential for determining the amount of confidence in the parameters' estimates. The 
essential parameters requiring these estimates are the rate constant and energy of 
activation. Confidence in the rate constant can be evaluated using linear and non-linear 
models. Techniques used to solve non-linear models give only approximations of the 
errors associated with the estimates, whereas linear models allow for more robust error 
calculations. In a linear model, reaction data are fitted to a linear equation. In first-order 
reactions, this takes the form of: 
In [A] = In [&] - kt [2.9] 
where A, and A are the concentrations of the drug at time = 0 and t, respectively. and k 
is the rate constant. Confidence intervals for the rate constant can be calculated by 
treating the k values as individual observations (i-e. one k value from one set of time- 
concentration data) or as a function of several values (i.e. linear regression anal-jsis). 
With linear regression analysis, all data points are used for the calculation of the k value, 
resulting in a large degrees of freedom which will give smaller estimates of the 
confidence interval for rate constants. 
The precision of E, can be determined by several different methods. Hill and 
Grieger-Block (1 980) determined the standard error of E3 by utilizing the errors 
calculated when determining temperatures and rate constants utilizing the following 
formula: 
( ~ I f b ) '  = (T*/T~-T 1)' (AT ,IT I)2 + (T JT2-~  112 ( A T ~ / T ~ ) ~  
+ [ lMk*kl)12 [ ( ~ k l k ) ~  + (~k2/k2)~] 
where: 
AEJE, = the standard enor of E, 
Akl(2Jkl(2, = the standard errors of kl or k2 
ATI(~)/T~(~) = the standard errors of TI and T2 
kl(21r TI(*) = the reaction rate constant and temperature (K) at which it 
was determined 
Another valid method for the determination of the precision of E, is the method 
reported by Carstensen (1995). This method utilizes all data points for calculating E, by 
performing a transformation on the observed data points as follows: 
In [(l/t)*ln(wA)] = EJRT + In P 
where: 
t = time (rnin) at which the data point was collected 
A, = concentration of reactant at time t = 0 minutes -
A = concentration of reactant at time t 
T = temperature (K) at which the concentration was determined 
R = gas constant ( 1.987 c a m  mol) 
P = pre-exponential function 
The advantage of this method is that because all data points are used in the calculation. 
the degrees of freedom is large and standard errors should be decreased. However, 
because of the exponential nature of the function, variance heterogeneity may occur 
which decreases the validity of the determined confidence interval. 
2.3 -3 History of Research on Processing and OTC Residues 
Studies on the effects of processing upon incurred OTC residues in tissues has 
traditionally been limited to observing absolute changes in the amount of OTC as a 
hnction of the procedure (Rutczynska-Skoniecna. 1967; Scheibner, 1969, 1972; 
Honikel et al., 1978; Shakaryan et al., 1976; O'Brien et al., 1980, I98 1; lbrahirn and 
Moats. 1994). A review by Moats ( 1988) summarized studies of the thermal 
inactivation of several classes of antibiotics. The review indicated that standard 
methodology has generally not been utilized; various food products of different sizes 
were subjected to different processes (e.g. boiling, fryng, roasting) of varying time 
lengths. Studies such as this provide a limited amount of information. as the amount of 
OTC loss can only be duplicated under identical conditions. Recently, studies have been 
done on the rate of OTC loss as a function of processing parameters (Kins et al., 1992; 
Rose et al., 1996). Kitts et al. (1992) performed a systematic study of the depletion of 
incurred OTC residues in f m e d  Chinook salmon, providing values for kinetic 
parameters and some statistical evaluation. Rose et al. (1996) studied the rate of OTC 
degradation in water and cooking oil. With a kinetic approach, it is possible to model 
losses of OTC in a system if parameters such as initial OTC concentration. size and 
shape of the tissue sample, and temperature are known. Such models could be used to 
predict how much OTC may b e  left in a system after being subjected to a given process 
which allows for better estimates of dietary OTC intakes. Since the incidence of finding 
O K  residues in pork tissue, particularly at injection sites, appears to be increasing 
(Agriculture and Agri-Food Canada, 1995), the probability of these same products being 
consumed also increases. A study of the rate of breakdown of OTC as a function of 
different meat processing practices would allow the appropriate agencies to better 
estimate the potential dietary intake of this substance. 
3. MATERIALS AND MXTHODS 
3.1 Chemicals and Materials 
All organic solvents were of Omnisolv grade (VWR-Caniab, Edmonton, AB); 
water was purified by means of a MiUi-Q purification system (Millipore, Mississauga, 
ON). Oxytetracycline was obtained from Sigma (St. Louis, MO); CepiOTC, a-apoOTC 
and P-apoOTC were obtained from Spectrum Chemical (Gardenia, CA). Tetra-sodium 
pyrophosp hate (S APP), penta-sodium tripolyp hosp hate (STP) and sodium 
hexametaphosphate (SH) were obtained from Caledon Laboratories (Edmonton, AB). 
Orthophosphate (SP) and all other reagents were of analytical reagent grade. Bond-Elut 
Cis cartridges (500 mg) were purchased from Varian Canada (Mississauga, ON). Frozen 
porcine tissue (semimembranoms and sernitendirzosus) was obtained from the Food 
Product Innovation Program (University of Saskatchewan, Saskatoon, SK) and analyzed 
to verify the absence of OTC residues. 
3 2 High-Performance Liquid Chromatography 
3.2.1 Extraction and Analysis of OTC and Related Compounds from Aqueous and 
Tissue matrices 
The liquid chromatograph consisted of a Beckrnan Model 342 HPLC system 
(Beckrnan Instruments, Berkeley. CA) containing a 20 pi injection loop. a Valco 2 Prn 
precolumn screen filter (Supelco Canada, Mississauga, ON) a Cs Inertsil (50 x 4.6 mm 
I.D.) guard-column and C8 Inertsil (250 x 4.6 mrn I.D.) analytical column (Lab Link. 
Rockford, IL) and a Waters 484 variable-wavelength detector (Millipore. Milford, MA). 
A Hewlett Packard 3390A integrator (Hewlett Packard, Avondale, PA) set at an 
attenuation of 2 mV was used for peak-area quantification. 
A statistical simplex design (Snee, 1979) was used to optimize mobile phase 
selectivity for the compounds and the design is as shown in Table 3.1. The solvents 
selected for the study were methanol (MeOH)(xl), tetrahydrofuran (THF)(x2) and 
acetonitrile (ACN)(x3). The selectivity of these solvents is due to their relative 
differences in solvent polarity, proton acceptor contribution, proton donor contribution 
and dipole contribution (Snyder, 1978) (Table 3 -2). A solvent strength equivalent to 
7 5 2 5  (v/v) 0.1M ammonium acetate (pH 3.0) buffer-acetonitrile was used as the starting 
point, as this is the recommended mobile phase in Method TTC-SPO5 (Agriculture and 
Agri-Food Canada, 1990). The chromatographic optimization hnction (COF) was 
calculated according to the formula of Glajch et al. (1 980); 
COF = h(R, / R d )  
where R, is the resolution of the ith peak pair in the chromatogram. Rd is the desired 
peak-pair resolution in the chromatogram, and k is the number of peak pairs. & was set 
to a value of 1.5; peak pair(s) with a resolution (Ri) greater than or equal to 1 . j  were 
given equal value. All possible peak-pair combinations were taken into account during 
the calculation of the COF values. Data were fitted to quadratic and special cubic 
models and analysed using the PROC REG procedure of the SAS Institute Inc. ( 1989) to 
determine the optimal mobile phase composition. Standards containing I mgirnl of the 
compounds were utilized for analysis. 
Table 3.1. Ten-run simplex design for a triphasic organic solvent mixture. 
Run Coded Values for solvents 
Methanol Tetrahydrofuran Acetonitrile 
Adapted Eorn Snee ( 1  979). 
' COF, chromatographic opt id t ion  function. 
Table 3 2. Selectivity parameter values of chosen organic solvents. 
Solvent Pa xeb Xd' Xn" 
Methanol 5.1 0.48 0.22 0.3 1 
Tetrahydro furan 
Adapted from Snyder (1978) 
'P. solvent polarity. 
bXe, proton acceptor contribution. 
Xd. proton donor contribution. 
*Xn, dipole contribution. 
The calibration curves for OTC (calculated on its free base) and CepiOTC were 
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obtained at 350 nm. Calibration curves for a- and P-apoOTC were obtained at 250 nm. 
Purity determination of the 4-epiOTC, a- and P-apoOTC preparations were not camed 
out; however, Khan et al. (1992) reported the respective purities of preparations 
obtained from the same source to be 84.5 %, 94.3 % and 95.2 %. Current purities are 
claimed to be greater than 95% (Acros Organics, 1998). These purities were not taken 
into account when determining the regression equations md were assumed to be 100 % 
pure for calculation purposes. 
Preparation methods for samples and standards are given in detail in Method 
TTC-SP05 of the Agriculture and Agri-Food Canada's Methods Manual (Agriculture 
and Agri-Food Canada, 1990). The efficacy of the procedure outlined in Method TTC- 
SP05 for the extraction of OTC and degradation products from fortified distilled water 
and pork muscle was investigated at concentration levels of 2000, 1000, 200 and 100 
nghl  (g). Distilled water (5 ml) or homogenized meat samples (5 g) were fortified with 
appropriate amounts of 10 or 1 mdml  methanol stock solutions of the compounds to 
give the final desired concentrations. The samples were blended with 20 rnl of 0.1 M 
NazEDTA McIlvaine buffer (pH 4.0), and centrifiged at 1000 x g for 10 rnin. The tissue 
plug was re-extracted twice more using 20 and 10 ml of buffer, respectively. The 
combined filtrates were applied to a 500 mg Bond-Elut C I g  cartridge previously 
activated with methanol and water, and then washed with 20 ml of distilled water. The 
compounds were eluted with 7 ml of 0.01 M methanolic acid, and diluted to 10 ml with 
distilled water. Triplicate analyses for each concentration were obtained; the average of 
each andysis was determined from duplicate injections. Peak area quantification was 
used to determine the recovery (%) £?om the two matrices. 
3 -2.2 Determination of OTC Degradation Kinetics 
The HPLC system consisted of a Waters 600E pump, a Waters 7 15 ULTRA 
WISP autosampler set at an injection volume of 100 p1, and a Waters 996 photodiode 
m a y  detector acquiring spectra in the wavelength range of 240-450 nrn with a resolution 
of 1.2 nm and a data acquisition rate of 1 spectral4 sec. Peak heterogeneity was 
assessed by the photodiode array software option of Millennium Chromatography 
Manager V 2.10 software. Peak area counts for OTC were obtained at 3 50 nm; peak 
area counts for other peaks were obtained at 250 nm. All other parameters are as 
indicated in section 3.2 .1 .  
3.3 Determination of OTC Degradation Kinetics 
3.3.1 Test Matrices/Media 
Table 3 -3  summarizes the composition of all aqueous media utilized during the 
determination of OTC degradation kinetics. Table 3.4 summarizes the composition of 
tissue media utilized during the determination of OTC degradation kinetics. 
Table 3 -3.  Aqueous matrices utilized during study. 
Number Media ~orn~o~tion/Descri~t ion 
1 Distilled Water 
2 GlyceroUdistilled water 0.9 a. @ 20°C 
3 GlyceroVdistilled water 0.8 a, @ 20°C 
4 GlyceroYdistilled water 0.6 a, @ 20°C 
5 SP buffer (pH 5.5.0.01 M) 
6 SP buffer (pH 5.5, 0.05 M) 
7 SF buffer (pH 5.5,O.l M) 
8 SP buffer (pH 4.0, 0.1 M) 
9 SP buffer (pH 7.0, 0.1 M) 
10 SP buffer + 0.1 M NaCl (pH 5.5, 0.05 M) 
11  SP buffer + 0.4 M NaCl (pH 5.5, 0.05 M) 
12 Acetate buffer (pH 5.5, 0.01 M) 
13 Acetate buffer (pH 5.5, 0.05 M) 
14 Acetate buffer (pH 5.5. 0. l M) 
15 Acetate buffer + 0.01 M SP (pH 5.5, 0.05 M) 
16 Acetate buffer + 0.03 M SP (pH 5.5, 0.05 M) 
I7 Acetate buffer + 0.05 M SP (pH 5.5, 0.05 M) 
I8 Acetate buffer + 0.01 M SAPP (pH 5.5, 0.05 M) 
19 Acetate buffer + 0.03 M SAPP (pH 5.5, 0.05 M) 
20 Acetate buffer + 0.05 M SAPP (pH 5.5, 0.05 M) 
2 1 Acetate buffer + 0.01 M STP (pH 5.5, 0.05 M) 
22 Acetate buffer + 0.03 M STP (pH 5.5. 0.05 M) 
23 Acetate buffer + 0.05 M STP (pH 5.5, 0.05 M) 
24 Acetate buffer + 0.01 M SH (pH 5.5. 0.05 M) 
25 Acetate buffer + 0.03 M SH (pH 5.5, 0.05 M) 
26 Acetate buffer + 0.05 M SH (pH 5.5, 0.05 M) 
27 Acetate buffer + 0.01 M CaC12 (pH 5.5,  0.05 M) 
28 Acetate buffer + 0.1 M CaClz (pH 5.5, 0.05 MJ 
29 Acetate buffer + 0.003 M NaN02 (pH 5.5, 0.05 M) 
Table 3.3.  Tissue matrices utilized during study. 
Number Media Cornposition~Description 
1 Porcine tissue diluted 9: 1 with acetate buffer (pH 5 .5 ,  0.1 M final conc. ) 
Porcine tissue diluted 3 :2 with acetate buffer (pH 5.5, 0.1 M final conc. ) 
Porcine tissue diluted 9: 1 with acetate bufferMac1 solution (0.4 M NaCI. 
pH 5.5, 0.1 M final conc.) 
Porcine tissue diluted 9: 1 with acetate buEer/CaClz solution (0.4 M CaCIZ, 
pH 5.5, 0.1 M final conc.) 
Porcine tissue diluted 9: 1 with acetate buffer/SP solution (0.5 % SP, pH 5.5, 
0.1 M final conc.) 
Porcine tissue diluted 9: 1 with acetate buffer1SAPP solution (equivalent to 
0.5 % SP. pH 5 . 5 ,  0.1 M final conc.) 
Porcine tissue diluted 9: 1 with acetate bufferISTP solution (equivalent to 0.5 % 
SP. pH 5.5, 0.1 M find conc.) 
Porcine tissue diluted 9: 1 with acetate buffedSH solution (equivalent to 0.5 % 
SP, pH 5.5, 0.1 M final conc.) 
Porcine tissue diluted 9: 1 with acetate buffer1EDTA solution (0.2 M EDTA, pH 
5.5, 0.1 M final conc.) 
Porcine tissue diluted 9: 1 with acetate bufferMaNOz solution (200 ppm NaN02. 
pH 5 .5 ,  0.1 M final conc.) 
1 -  
3 .J 2. Protocol 
The thermal stability of OTC was investigated at 60, 70, and 80°C (+ 1°C) in the 
aqueous and tissue media listed in section 3.3.1. Distilled water solutions were adjusted 
to water activities (a&) of 0.9, 0.8 and 0.6 (k 0.0 1)  at ambient temperature using 
glycerol. and the aW7s were verified by a Model CX-1 Decagon Water Activity Meter 
(Decagon Devices, Inc.. Pullman, WA). All other media were prepared immediately 
before use. Three rnl of the media were dispensed into 50 ml round-bottom glass 
centrifbge tubes (VWR-Canlab, Edmonton, AB) and 100 p1 of 1 m g h l  methanolic OTC 
was added. The tubes were sealed with Teflon lined caps, placed in constant 
temperature water baths (Biichi. Switzerland) and removed at intervals ranging from 0 to 
60 minutes. and cooled immediately in ice water. OTC was extracted from the aqueous 
matrices as described in section 3 -2.1. Come-up temperature profiles were monitored 
using an OMEGA microprocessor thermometer with a T-type thennocouple (Omega 
Engineering, Inc., Laval, QC). Steady-state temperatures (within 1°C of the desired 
temperature) were obtained within 1 0 minutes. 
OTC degradation in porcine tissue was monitored in a similar manner. Porcine 
tissue was preground in a commercial blender, frozen. and stored at -20°C for a period 
no longer than one month prior to use. Ground tissue (5.0 f 0.1 g) was added to 50 ml 
round bottom glass centrfige tubes, and 100 pl of I mg/ml methanolic OTC was added. 
Immediately after preparation, 500 pl of the treatment was added to the tubes (section 
3 -3.1) and mixed. The tissue was packed to the bottom using a rubber-tipped syringe 
plunger, sealed, and themally treated for 0 to 60 minutes. The come-up temperature 
profile of the geometric center of the tissue mass was monitored as indicated for the 
aqueous media. ). Steady-state temperatures (within I°C of the desired temperature) 
were obtained within 10 minutes. 
3 . 3  3 Data Analysis 
Thermal destruction constants (tb, mid) of OTC and their associated 95 % 
confidence intervals were obtained from linear regression equations, n= 18, of the In peak 
area counts as a function of time using Excel V 5.0 (Microsofl Corporation, Redrnond, 
WA). Energy of activation (E, kcal/mol) values and the associated standard errors were 
calculated according to Hill and Grieger-Block (1980) using bb, and standard errors 
obtained at 60 and 80°C. Changes in enthalpy (AK) and entropy (AS) were calculated 
according to Carey and Sundberg (1990) using kb. obtained at 60, 70 and 80°C. The 
isokinetic temperature was determined by the method of Leffler (1 955) using all AH and 
AS values obtained. Power analysis for the hb, obtained were calculated using obtained 
estimates of standard errors (60°C. -0.0008: 70°C. -0.002; 80°C, -0.005) 
Where possible, estimation of the rates of formation and degradation of OTC 
degradation compounds was accomplished by fitting data to a four parameter 
biexponential equation: 
A = pl<"L - p p f l  [3.2] 
where P 1 and P2 are pre-exponential constants, is the rate of destruction of the 
unknown compound and kf is the rate of formation of the unknown compound. The 
PROC NLIN using the DUD iterative procedure of SAS (SAS Institute Inc.. 1989) was 
used to obtain estimates and corresponding standard errors of the parameters. Initial 
estimates and boundaries for PROC NLM were provided by the manual technique of 
"feathering" the data (Shargel and Yu, 1993). 
3.4 Determination of MeatDSA Binding of OTC. 
The determination of OTC binding was a modification of the method by Yuan et 
al. (1995). Using a commercial grinder, 2 g of porcine tissue was ground with 98 rnl of 
0.1 M sodium acetate buffer for 30 seconds. Three rnl of the homogenate was blended 
with 2 rnl of 0.065 % (wlv) dextran (MW 70,000), 0.6 % (wlv) activated charcoal 
solution in 0.1 M sodium acetate buffer, pH 5.5. A 100 pl portion of 100 mg/rnl 
methanolic OTC was added to the mixture. The solution was mixed for times ranging 
from 30 to 540 seconds, filtered though a glass microfibre filter to separate the charcoal 
from the supernatant, and analyzed for OTC content as outlined previously. The data 
was fitted to a four parameter biexponential equation: 
B(t) = P 1 e" + p2e4' 
where B(t) is the amount (area counts) obtained for OTC at time t 
a = the composite association constant of drug to charcoal (s-') 
p= the composite dissociation constant of drug from tissue/BSA (s-') 
The PROC NLM procedure using the DUD iterative option of SAS (SAS 
Institute Inc., 1989) was used to obtain estimates and corresponding standard errors of 
the parameters. Initial estimates and boundaries for the parameters were provided by the 
manual technique of "featheringy7 the data (Shargel and Yu, 1993). 
4. RESULTS 
4.1 Analysis and Quantification of OTC and Degradation Compounds from Aqueous 
and Tissue Matrices 
4.1.1 Optimization of Chromatographic Separation of OTC and Degradation 
Compounds 
According to the solvent classitication scheme of Snyder (1978) as cited by 
Glagch et al. (1 980) the calculated polarity strength of a 7525 (vlv) buffer-ACN mobile 
phase (assuming the aqueous buffer has the same eluting strength as water) would be 
9.2. At a flow-rate of 0.6 d m i n ,  elution times for OTC and degradation products were: 
OTC, 10.5 min; CepiOTC, 1 1.2 min; a-apoOTC, 10.4 min; P-apoOTC, 3 1.2 rnin. 
Calculated compositions for equal polarity (equal to 7525 (v/v) buffer-ACN) buffer- 
methanol and buffer-tetrahydrofuran mobile phases were 7 8 2 2  (v/v) and 82: 18 (vlv), 
respectively. With the calculated buffers as the mobile phase, elution of the primary 
compound (OTC) occurred at 40 min with buffer-methanol and 23 min with buffer- 
tetrahydrohran, respectively. Trial and error formulation of the buffer phases resulted in 
a final binary-phase composition of buffer-methanol 55% (vh )  (OTC. 10.8 min) and 
buffer-tetrahydrohran 70:30 (v/v) (OTC, 12.0 i n ) ,  corresponding to calculated polarity 
strengths of 7.9 and 8.3 respectively, lower than was calculated. The actual mobile 
phase compositions tested according to the ten-run simplex design were as indicated in 
Table 4.1. The COF values and adjusted retention times (unretained solvent time. 3.9 
min) for the four components were obtained (Table 4.2). Relative standard deviations 
for the adjusted retention times and COF values were less than 5 and 10 % of the means, 
Table 4.1. Mixture formulations for optimization experiment. 
Run MeOH THF ACN Buffer 
1 45.00 0.00 0.00 55.00 
2 0.00 30.00 0.00 70.00 
3 0.00 0.00 25.00 75 -00 
4 22.5 15-00 0.00 65.00 
5 22.5 0.00 15.00 62.50 
6 0.00 15.00 12.5 72.50 
7 15.00 8.33 10.00 66.77 
8 30.00 4.17 5 -00 60.83 
9 7.5 16.7 5.00 70.80 
10 7.5 4.17 20.00 68.33 
Values in % (vlv) 
Table 4.2. Adjusted retention times and COF values for oxytetracycline and 
degradation compounds, and subsequent liquid chromatograph operating 
pressure (n=3). 
Run Adjusted retention time (min) Pressure 
respectively. In general, it was observed that mobile phases incorporating 
tetrahydrohran (strong dipole interaction, weak proton donor) effected a better peak 
separation than those without terrahydrofuran. 
The COF values obtained from the experiments (runs 1- 10) were fit to both 
quadratic and cubic equations. The response y as described by the quadratic model was: 
E(y) = -886(x 1 ) -O.78(Ll) -3.2 1(x3) + 19.72(~  1 *G) 
+ 2.43 (xl*x3) + 8.72(x2*x3) P . 1  1 
where XI.  .a and x3 are the coded values of methanol, tetrahydrohran and acetonitrile 
in the simplex design used for optimization. The response y as described by the cubic 
equation was: 
E(y) = -8.74(~1) - 0.65(~2) -3.08(~3) + 15 .80 (~1*~2)  - l.47(xl *d) 
t 4.82(x2*?il) + 63.41 (XI  *x2*x3) (4.21 
Tabulated F-ratios (a=0.05) for the quadratic and cubic models were 2.5 1 and 7.45. 
respectively. Calculated F-ratios for the lack of fit were 85 and 8 1. respectively. 
indicating that a significant lack-of-fit is present for both proposed models and that the 
models do not adequately describe the COF response as a hnction of the volumes of the 
three organic solvents. The mobile phase with the highest COF value ( i - e  greatest 
resolution) was run 2 (Buffer-THF, 7030). However, the operating pressure was high 
(2170 p.s.i. ). Run 6 (Figure 4.1 ) has the second highest COF (-0.3 2) and also had a 
reasonably low operating back pressure ( 1.92 p.s.i.). This mobile phase was 
subsequently utilized for brt her experiments. 
Figure 4.1 HPLC chromatogram of OTC and related degradation compounds from 
run 6 ( I )  a-apoOTC. (2) OTC. (3) I-epiOTC. (4) P-apoOTC 
Table 4.3 Regression statistics for OTC. CepioOTC, a- and P-apoOTC for 
regression curves of peak-area counts as a function of concentration 
(nghl)  (n= 1 2). 
Regression 
Statistics 
OTC 
Intercept 
S.E." 
x-variable 
S.E. 
R' 
"S.E., standard error. 
Regression statistics for the relationship between compound concentration and 
peak-area counts are shown in Table 4.3. The correlation coefficient exceeded 0.98 for 
all regression equations. The limits of detection for OTC, CepiOTC, a- and P-apoOTC 
were 40. 20. 50. and 140 ng/ml, respectively under the given experimental conditions. 
4.1.2 Recovery of OTC and Degradation Compounds from Aqueous and Tissue 
Matrices 
Recovery data of OTC and degradation compounds from distilled water and pork 
tissue are reported in Tables 4.4 and 4.5. Recovery of OTC was greater than 90 % fiom 
distilled water for all concentrations investigated. Recovery of CepiOTC, a- and P- 
apoOTC were lower than OTC, and the percentage recovery appeared to be dependent 
upon the initial concentration. Recovery of OTC and CepiOTC from tissue were 
significantly lower (p < 0.05) than fiom distilled water, whereas recoveries of a- and P- 
apoOTC were sharply decreased, with P-apoOTC recovery being reduced to less than 10 
% at concentrations of 2000 and 1000 nglrnl, and no detectable levels being found at 
concentrations of 200 and 100 ng/rnl. Elution using acetonitrile, tetrahydrohran and 
ethanol containing 0.01 M oxalic acid did not improve recoveries, and were highly 
iceproducible (data not shown). 
Table 4.4. Recovery of OTC and degradation products from 5 ml of distilled waxer 
fortified at four different levels (n=3). 
Spike level Recovery (%) (CV, %) 
( W m l )  
OTC CepiOTC a-apoOTC P-apoOTC 
2000 99.0 (0.7) 83.4 ( 1 . 3 )  88.9 (5.6) 84 .3  (16.9) 
a ND, not detected. 
Table 4.5. Recovery of OTC and degradation products i?om 5 g of homogenized 
porcine tissue fonified at four different levels (n=3)- 
Spike [evel Recovery (%) (CV. %) 
( n g / d )  
OTC 4-epiOTC a-apoOTC P-apoOTC 
2000 83 .7  (2.4) 57.5 (4.6) 40.0 (3.7) 8.9 ( 1 l 4) 
" XD. not detected. 
4.2 Effects of Treatments and Thermal Processing on OTC Degradation 
4.2.1 Water Activity 
The influence of glycerol adjusted water activities ranging from 0.6 to 1.0 upon 
the rate of OTC degradation at 60, 70, and 80°C. with the appropriate kinetic 
parameters, are shown in Tables 4.6 and 4.7. Rate constants ranged fiom -0.0043 to - 
0.0073 mine' at 60°C, whereas at 80°C they ranged from -0.05 10 to -0.0575 min" No 
statistically significant difference was seen between rate constants at a given temperature, 
though trends (0.05 < p < 0.20) were noted. The calculated E, for distilled water was 
higher than that obtained for the giycerol./distilled water solutions; additionally, AS 
values were positive for degradation in distilled water, whereas reactions in 
glycerolldistilled water solutions were negative. Change in enthalpy values ranged fiom 
22 kcaUmo1 to 29 kcal/mol. The degradation of OTC at 80°C in distilled water is shown 
in Figure 4.2. 
Table 4.6. OTC degradation parameters kobs ( m i d )  and E, (kcaVmo1) in aqueous 
media as affected by water activity. 
Medium T e m ~  ("C) mean 95 % c.i. mean s . E . ~  
Distilled Water 60 
70 
80 
GiyceroVdistilIed water 60 
(0.9 aw @ 20°c) 70 
80 
GlyceroVdistilled water 60 
(0.8 aw@ 20 '~ )  70 
80 
GlyceroVdistilled water 60 
(0.6 a,@ 2 0 ' ~ )  70 
80 
a n=18, linear regression of 1n[OTCtimet] = 1n[OTCtime=o] - kobst. 
b standard error. 
Table 4.7. Changes in enthalpy (w kcal/mol) and entropy (AS, caV mol K) for 
' OTC degradation at different water activities. 
AH AS 
Medium (kcaVmol) (caYmol K) 
Distilled Water 
GlyceroVdistilled water (0 -9 aw @ 2 0 ' ~ )  
GlyceroVdistilled water (0.8 @ 20°c) 
GlyceroUdistilled water (0.6 @ 2 0 ' ~ )  
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Figure 4.2. Concentration-time profile of OTC in 80°C distilled water. 
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4.2.2 Orthophosphate Buffer 
Increasing phosphate buffer concentration Born 0.0 1 to 0.1 M significantly 
increased most rate constants at temperatures &om 60-80°C (Table 4.8). The buffer free 
degradation rate constant (t) was calculated using the equation (Carstensen, 1995): 
kobs = ko + ~ H Q ~ Q ]  WI 
where: 
= rate constant at a buffer concentration of 0 M 
kHQ = rate constant as a fhction of phosphate buffer concentration 
PQJ = phosphate buffer concentration (M) 
Plots of bb, for OTC degradation at different phosphate concentrations and 
temperatures are shown in Figure 4.3. The k, values at 60, 70 and 80°C were -0.0049, 
-0.0 15 1 and -0.0586 mid', respectively, which compared favourably with the rate 
constants obtained in distilled water. The kHQ values at 60. 70 and 80°C were -0.1360, 
-0.3442 and -0.37 15 mid. respectively. The calculated E,, AH and AS values (Table 
4.9) for k, (29.0, 28.3 and 7.6 kcallmole respectively) also compared favourably with 
those obtained in distilled water. The qualitatively higher values for kHQ, as well as the 
lower E,, AH and AS values obtained for those solutions containing phosphate buffer, 
indicated that phosphate buffer had a strong catalytic effect upon the degradation of 
OTC. 
Degradation of OTC in pH 4 and 7 phosphate buffers (0.1 M) was significantly 
(p < 0.05) lower at all temperatures than the corresponding degradation rates in pH 5.5 
buffer. E,, AH and AS values also differed substantially, indicating that the different pH 
andfor different amounts of buffer species affected the rate of degradation of OTC. 
Tabie 4.8. OTC degradation parameters kobs ( m i d )  and E, (kcaVrnol) in aqueous 
media as affected by phosphate buffer and sodium chloride concentration, 
and pH. 
Medium 
kobs(min- I)' E, (kcalfrnol) 
Temp ("C) mean 95 % c.i. mean s . E . ~  
Phosphate Buffer 
(pH 5.5, 0.01 M) 
Phosphate Buffer 
(pH 5.5, 0.05 M) 
Phosphate Buffer 
(pH 5.5, 0.1 M) 
Phosphate Buffer 
(pH 4.0, 0.1 M) 
Phosphate Buffer 
(pH 7.0, 0.1 M) 
Phosphate Buffer 
+ 0.1 M NaCl 
(pH 5.5 ,  0.05 h.0 
Phosphate Buffer 
+ 0.4 M NaCl 
(pH 5.5, 0.05 M) 
a n=18, linear regression of in[OTCtime-=] = ln[OTCtjme=o] - kobst. 
standard error. 
Table 4.9. Changes in enthalpy (AH, kcdmol) and entropy (AS, caVmol K) for OTC 
degradation at different phosphate buffer and sodium chloride 
concentrations, and pHs. 
Medium (kcal./rnol) (cdrnol K) 
Phosphate Buffer (pH 5.5,  0.01 M) 23.52 -5.86 
Phosphate Buffer (pH 5.5, 0.05 M) 
Phosphate Buffer (pH 5.5.0.1 M) 
Phosphate Buffer (pH 4.0, 0.1 M) 
Phosphate Buffer (pH 7.0,O. l M) 21.67 - 1  1.86 
Phosphate Buffer + 0.1 M NaCI (pH 5.5, 0.05 M) 21.41 - 1  1.54 
Phosphate Buffer + 0.4 M NaCI (pH 5.5, 0.05 M) 22.97 -9.10 
I i Temp (OCI 1 
-0.1 
0 0.02 0.04 0.06 0.08 0.1 
Orthophosphate Concentration 
Figure 4.3. Rate of OTC degradation (bta, mid) at 60-80°C in orthophosphate 
buffers of different concentrations. 
4.2.3 Sodium Chloride 
The effect of ionic strength upon OTC degradation was investigated using two 
different concentrations of NaCl in 0.05 M phosphate buffer, pH 5.5. There were no 
significant differences (p < 0.05) in bh noted at all temperature-concentration 
combinations (Table 4.8). A substantial drop in entropy (-3.66 for control to - 1 1.54 and 
-9.10 caVmol K for 0. l M and 0.4 M solutions of NaCI, respectively) was also noted 
(Table 4.9). AU other kinetic parameters exhibited entha!py/entropy compensation 
(section 4.2.8) which indicated that no change in the mechanism of OTC degradation 
occurred. 
4.2.4 Acetate Buffer/Polymeric Phosphates 
The rates of OTC degradation with associated kinetic parameters in acetate 
buffers are shown in Table 4.10. At 6O0C, the rate constants, which ranged from - 
0.0063 to -0.007 1 min", were not significantly different between the varying acetate 
buffer concentrations at pH 5.5. At 70°C. the rate constant in 0.1 M acetate buffer (- 
0.02 12 m i d )  was significantly greater than in 0.0 1 M acetate buffer (-0.0 172 min-'). At 
80°C. the rate constant in 0.0 1 M acetate buffer (-0.0443 rnin-') was significantly lower 
than in 0.05 M or 0.1 M acetate buffer. The E, values for the three buffers ranged from 
22.86 to 26.36 kcaVrno1. Analysis of covariance of bb, as a function of temperature with 
acetate buffer concentration as the covariate indicated that buffer concentration did not 
have an identifiable influence upon the rate constants (p > 0.05). E, values ranged from 
18 kcaVmol to 25 kcal/mol. 
Table 4.10. OTC degradation parameters kobs (min-I) and E, (kcdrnol) in aqueous 
media as affected by acetate buffer concentration and inclusion of 
monomeric and polymeric phosphates. 
kobdmin-' f E, (kcaUmo1) 
Medium Temp ( O C )  mean 95 % c.i. mean s .E .~  
Acetate Buffer 
(pH 5 .5 ,  0.01 M) 
Acetate Buffer 
(pH 5.5 ,  0.05 M) 
Acetate Buffer 
(pH 5.5, 0. l M) 
Acetate Buffer 
+ 0.01 M SP 
(pH 5 . 5 .  0.1 M) 
Acetate Bufer 
+- 0.03 M SP 
(pH 5 . 5 ,  0.1 M) 
Acetate Buffer 
+ 0.05 M SP 
(pH 5.5, 0.1 M) 
Table 4.10. Continued. 
kobs(rnin- I)' E, (kcaUmot) 
Medium Temp (T) mean 95 % c.i. mean s .E .~  
Acetate Buffer 
+ 0.01 M SAPP 
(pH 5.5. 0.1 M) 
Acetate Buffer 
+ 0.03 M SAPP 
(pH 5 . 5 .  0.1 M) 
Acetate Buffer 
+ 0.05 M SAPP 
(pH 5 . 5 ,  0.1 M) 
Acetate Buffer 
+0.01 M STP 
(pH 5.5. 0.1 M) 
Acetate Buffer 
+ 0.03 M STP 
(pH 5.5, 0.1 M) 
Acetate Buffer 
+ 0.05 M STP 
(pH 5.5,  0.1 M) 
Table 4.10. Continued. 
kobs(min- f E, (kcaVmol) 
Medium Temp (OC) mean 95 % c.i. mean s . E . ~  
Acetate BufTer 60 -0.0050 (-0.0064, -0.0036) 24.52 2.97 
(pH 5.5, 0.1 M) 80 -0.0408 (-0.0430,-0.0387) 
Acetate Buffer 60 -0.0052 (-0.0071, -0.0033) 23 -72 2.70 
+ 0.03 M SH 70 -0.0150 (-0.0171,-0.0130) 
(pH 5.5, 0. l M) 80 -0.0396 (-0.04 13, -0.0379) 
Acetate Buffer 
+ 0.05 M S H  
(pH 5.5, 0.1 M) 
a n = 18, linear regression of In[OTCtime-I] = h[OTCtime=~] - kobst. 
b standard error. 
Table 4.1 1. Changes in enthdpy (AH, kcal/mol) and entropy (AS, cdrnol K) for OTC 
degradation at different acetate buffer and phosphate concentrations. 
AH AS 
Medium (kcaVmol) (cahol  K) 
Acetate Buffer (pH 5.5, 0.01 M) 22.10 - 10.60 
Acetate Buffer (pH 5.5, 0.05 M) 25.69 0.2 1 
Acetate Buffer (pH 5.5, 0.1 M) 23 .07 -7.45 
Acetate Buffer + 0.0 1 M SP (pH 5.5, 0.1 M) 23.66 -5.57 
Acetate Buffer + 0.03 M SP (pH 5.5, 0.1 M) 26.8 1 3.68 
Acetate Buffer + 0.05 M SP @H 5.5, 0.1 M) 23.05 -7.23 
Acetate Buffer + 0.01 M SAPP (pH 5.5, 0.1 M) 26&08 1.05 
Acetate Buffer + 0.03 M SAPP (pH 5.5,  0.1 M) 24.57 -3.41 
Acetate Buffer + 0.05 M SAPP (pH 5.5, 0.1 M) 25.00 -2.11 
Acetate Buffer+ 0.01 M STP (pH 5.5, 0.1 M) 
Acetate Buffer + 0.03 M STP (pH 5.5, 0.1 M) 
Acetate Buffer + 0.05 M STP (pH 5.5, 0.1 M) 24.64 -3.37 
Acetate Buffer + 0.01 M SH (pH 5.5, 0.1 M) 23.83 -5 86 
Acetate Buffer + 0.03 M SH (pH 5.5, 0.1 M) 23 .03 -8.18 
Acetate Buffer + 0.05 M SH (pH 5.5. 0- 1 M) 23.14 -7.84 
Varying phosphate concentration in 0.1 M acetate buffer did not have as 
t 
significant an effect upon the rate of degradation as phosphate buffer alone. Increasing 
the concentration of phosphate in 0.1 M acetate buffer did not have any effect at 60 and 
70°C; a significant increase occurred in 0.03 M SP at 80°C as compared to 0.1 M 
acetate buffer control. E,, AH and AS values were qualitatively similar (Table 4.1 1). 
SAPP appeared to have a weak inhibitory effect upon OTC degradation. 
Varying the concentration from 0.01 M to 0.05 M significantly decreased the rate of 
degradation at 60 and 70°C, at 80°C, this was not apparent. There was no difference 
observed between SAPP buffers. E,, AH and AS values were qualitatively similar. 
STP was inconsistent in its ability to decrease the rate of OTC degradation. No 
significant differences were noted at 60°C. whereas at 70°C all concentrations tested 
significantly (p < 0.05) decreased the rate of degradation. At 80°C, only 0.03 M STP 
significantly decreased k,,*. All other kinetic parameters were similar. 
SH consistently decreased the rate of OTC degradation at most temperature- 
concentration combinations as compared to control. No significant differences were 
observed for t h  within the different concentrations. All other kinetic parameters were 
similar to each other. 
4.2.5 CalciumChloride 
The inclusion of CaC12 into acetate buffer at 0.0 1 M significantly decreased tb, at 
70 and 80°C over that of control (Table 4.12). At 0.1 M, CaC12 significantly decreased 
kb at 60, 70 and 80°C over that of the control; at 70 and 80°C kb was significantly 
lower than that for 0.0 1 M CaC12 solution at the same temperatures. Qualitatively. E,, 
AH and AS were less than the corresponding parameters in the control and 0.0 I M CaC12 
(Table 4.13); however, the associated errors with these parameters were much greater. 
4.2.6 Sodium Nitrite 
The use of NaN02 at 0.003 M NaN02 (ca. 200 ppm sodium nitrite) did not have 
any sigruficant effects upon OTC degradation. However, at 70°C, nitrite increased the 
mean k,,h, whereas at 80°C it decreased the mean kb, over control (0.05 < p < 0.10). 
Qualitatively, all other kinetic parameters were lower in the nitrite containing solution 
than in the control solution. 
Tabie 4.12. OTC degradation parameters kobs (min-1) and E, (kcaVmol) in aqueous 
media as a6ected by calcium chloride and sodium nitrite. 
kobs(min- 1)' E, (kcaL'mol) 
Medium Temp ("C) mean 95 % c.i. mean s . E . ~  
Acetate Buffer 60 -0.007 1 (-0.0079, -0.0063) 23.80 2.14 
(pH 5.5, 0.1 M) 70 -0.02 12 (-0.0227, -0.0 198) 
Acetate Buffer 60 -0.0044 (-0.0072, -0.00 16) 24.39 4.23 
+ 0.01 M CaCI, 70 -0.0112 (-0.0148,-0.0076) 
(pH 5.5, 0.1 M) 80 -0.0357 (-0.0404, -0.03 10) 
Acetate Buffer 60 -0.0028 (-0.0053, -0.0003) 16.85 6.09 
+ 0.1 M CaCl, 70 -0.0046 (-0.0076, -0.00 1 5 )  
(pH 5.5, 0.1 M) 80 -0.0119 (-0.0172,-0.0066) 
Acetate Buffer 60 -0.0070 (-0.0082, -0.0058) 21 -48 2.24 
+ 0.003 M NaNO, 70 -0.0245 (-0.0265, -0.0226) 
(pH 5.5, 0.1 M) 80 -0.0436 (-0.0490, -0.0382) 
a n=18, linear regression o f  ln[OTCtime=t] = h[OTCtime=~l - kobst. 
b standard error. 
Table 4.13. Changes in enthalpy (AH, kcaUmol) and entropy (AS. caVmol K)  for OTC 
degradation in the presence of calcium chloride and sodium nitrite. 
AH AS 
Medium (kcdmol)  (caYmol K) 
Acetate Buffer + 0.01 M CaCI, (pH 5.5, 0.1 M) 23.74 -6.39 
Acetate Buffer + 0.1 M CaCl, (pH 5.5, 0.1 M) 16.16 -3 0.04 
Acetate Buffer + 0.003 M NdO, (pH 5.5, 0.1 M) 
4.2.7. Porcine Tissue 
4.2.7.1 Porcine Tissue and 0.1 M Acetate Buffer 
Incorporation of OTC into porcine tissue with 10 % (wlw) of 1.0 M acetate 
buffer (final acetate concentration = 0.1 M) significantly decreased the rate of Of C 
degradation at all tested temperatures as compared to 0.1 M acetate buffer (Table 4.14). 
The kinetic parameters were qualitatively similar between the two systems (Tables 4.15 
and 4.1 1, respectively). Increasing the amount of acetate buffer to 60 % (w/w) o f  tissue 
(acetate concentration adjusted to give a ha1  acetate concentration of 0.1 M), 
significantly decreased tb, only at 80°C. However, the kb, was significantly greater than 
the corresponding bb, in the 10 % (wlw) miwture at 60 and 70°C. AU secondary kinetic 
parameters were dramatically lower; the associated errors with E, remained relatively 
constant. The E,, AH and A S  values for the 10 % (wfw) and 60 % (wlw) mixtures were 
25.5 and 15.2 kcal/mol, 24.8 and 14.5 kcal/mol, and -3.26 and -32.6 kcal/mol, 
respectively. 
1.2.7.2 Porcine Tissue and Phosphates 
SP. SAPP. STP and SH were added to porcine tissue to give final concentrations 
equivalent to 0.5 % dibasic sodium phosphate. No significant differences in k,b were 
observed between porcine tissue containing SP and porcine tissue containing acetate 
buffer alone (control). All kinetic parameters for tissue containing SP, however, were 
qualitatively lower than the control. 
Table 4.14. OTC degradation parameters kobs ( m i d )  and E, (kcdmol) in tissue 
media as affected by different treatments. 
- 
kobd E, (kcaVmoI) 
Medium Temp (OC) mean 95 % c.i. mean s . E . ~  
-0.0042 (-0.0055, -0.0029) 25.52 3.04 Porcine Tissue 
Porcine Tissue 
3 :2 dil. With buffer 
(pH 5 - 5 )  
Porcine Tissue 
+ 0.4 M NaCl 
(pH 5 . 5 )  
Porcine Tissue 
+ 0.4 M CaC12 
(pH 5.5) 
Porcine Tissue 
+ SP (0.5 % final conc.) 
Table 4-13. Continued. 
Medium Temp('C) mean 95 % c.i. mean s . E . ~  
Porcine Tissue 
+ SAPP 
(equivalent to 0.5 % SP) 
Porcine Tissue 
+ STP 
(equivalent to 0.5 % SP) 
Porcine Tissue 
+ SH 
(equivalent to 0.5 % SP) 
Porcine Tissue 
+ 0.2 M EDTA 
(pH 5 .5 )  
Porcine Tissue 
+ NaNO:! 
(200 ppm final conc.) 
a n= 18, linear regression of ln[OTCtime-=] = 1n[OTCtime=o] - kobst- 
standard error. 
Table 4.15. Changes in enthalpy (AH., kcal/mol) and entropy (AS. caVmo1 K) for OTC 
degradation in treated porcine tissue. 
Medium (kcaVmo1) (cdmol K) 
Porcine Tissue (pH 5 . 5 )  24.8 1 -3.26 
Porcine Tissue 3:2 dil. with buffer (pH 5.5) 
Porcine Tissue + 0.4 M NaCl (pH 5.5) 
Porcine Tissue + 0.4 M CaC12 (pH 5 -5) 
Porcine Tissue + SP (pH 5.5) 
Porcine Tissue + SAPP (pH 5.5) 
Porcine Tissue + STP (pH 5.5) 
Porcine Tissue + SH (pH 5.5) 
Porcine Tissue + 0.2 M EDTA (pH 5.5) 
Porcine Tissue + NaN02 (pH 5 . 5 )  
SAPP significantly increased k,,h at 80°C over control, with no substantial differences in 
the kinetic parameters fiom the control. STP significantly increased kb, at 80°C. as well 
it substantially increased the remaining kinetic parameters over that of control. SH 
significantly increased kb, at all temperatures at 60, 70 and 80°C. Kinetic parameters 
appeared to be slightly lower than that for control. 
4.2.7.3 Porcine Tissue and EDTA, NaCI, CaC12 and NaNOz 
The addition of EDTA to a final concentration of 0.2 M in porcine tissue 
significantly (p < 0.05) increased the rate of OTC degradation at 80°C over control 
tissue. There were no sigruficant differences in kb between tissue with EDTA and 0 I 
M acetate buffer (Table 4.14). Kinetic parameters were qualitatively similar. 
Addition of 0.4 M NaCl to porcine tissue significantly increased kb, at 60°C and 
significantly decreased Ch at 80°C compared to control (Table 4.14). Kinetic 
parameters were dramatically lower than those obtained for porcine tissue alone. Values 
for E,, AH and AS for porcine control and NaCl treatment were 25 .5  and 14.6 kcal/mol. 
24.8 and 13.9 kcai/mol, and -3.2 and -34.5 kcaYrnol. respectively. 
The addition of NaNOz to tissue significantly increased bb, at 60°C. whereas at 
80°C it significantly decreased bb. as compared to control. Changes in the remaining 
kinetic parameters were the most dramatic observed among all treatments vs. controls. 
Values for E,, AH and AS of the NaNOz treatment were 1 1.4. 10.6 and -44.7 kcal/mol. 
respectively. 
The presence of 0.4 M CaC12 in meat significantly lowered bb, at 70 and 80°C. 
Kinetic parameters were not substantially different from that of the control. 
4.2.8 Enthalpy/Entropy Compensation 
A plot of the AH as a function of AS for all reactions studies is shown in Figure 
1.4. Regression analysis of the data indicated that the isokinetic temperature of OTC 
degradation was 337 K. The 95 % confidence interval was 326 to 348 K with an R' of 
0.99. 
4.2.9 Power Analysis of Degradation Data 
Power curves for degradation of OTC using the assumed standard errors (Sec. 
3 - 3 3 )  are shown in Figure 4.5. A power of 80 % was obtainable when the unknown 
true difference in l ~ , ~  was approximately 0.0035, 0.008, and 0.02 rnin*' at 60, 70 and 
80°C, respectively. A cursory evaluation of the kinetic data obtained revealed that few 
estimated differences were this great, indicating that, in general. the power of these tests 
was less than 80 %. 
Figure 4.1. Entkalpy/Entropy compensation curve for OTC degradation under dl 
experimental conditions. 
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42-10 Formation of Degradation Compounds 
Quantification of degradation compounds could not be performed with accuracy 
for most treatments due to the presence of several overlapping peaks. Degradation of 
OTC in distilled water did allow for quantification of a chromatographic peak that eluted 
at 12 to 14 minutes. The photodiode array software indicated the peak was 
homogeneous in composition. Plots of average counts for the peaks at 60, 70 and 80°C 
are shown in Figure 4.6. A plot of the "feathering technique" used to obtain initial 
parameter estimates for SAS's PROC NLm procedure is shown in Figure 4.7. As this is 
a crude technique, the actual grid search estimates and parameter boundaries used for 
PROC NLIN (Table 4.18) were set reasonably wide. Parameter estimates, standard 
errors, and 95 % confidence intervals obtained by PROC NLIN are given in Table 4.19. 
The calculated F-values for lack-of-fit analysis were 16, 3.07 and 2.86 for equations 
obtained at 60, 70 and 80°C, respectively. All F-values were significant at p = 0.01. 
4.3 BSAlTissue Binding of OTC 
A typical plot of In area counts as a fbnction of time for OTC in the presence and 
absence of BSA is shown in Figure 4.8. Initial grid search estimates used for PROC 
NLIN procedure are shown in Table 4.18. Parameter estimates, standard errors and 95 
O/o confidence intervals are given in Table 4.19. F-values for lack-of-fit analysis of the 
- 
estimated models were all less than 1. None of the obtained results were significantly 
different from each other, though differences in mean P values were observed. Addition 
of phosphate to tissue numerically increased the P constant fiom 0.00 14 to 0.0040 s". 
20 40 
Time (min) 
Figure 4.6. Formation of unknown OTC degradation compound at 60, 70 and 80°C 
in distilled water. 
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Figure 4.7. Illustrative example of the "feathering technique" used to obtained 
preliminary grid-search estimates for PROC NLIN. 
Table 4.16. Preliminary grid search estimates used for PROC MDJ estimation of 
, 
' parameters for the biexponential model of unknown peak formation. 
Grid Search Estimates Used 
Parameters 
Temp (OC) P 1 (x 10") ~2 (x kf kd 
60 900 to 2000 by 900 to 2000 0.08 to 0.12 by 0.02 to 0.05 by 
200 by 200 0.0 1 0.0 1 
Table 4.17. Parameter estimates obtained for biexponential model of unknown peak 
formation. 
Parameter Estimates 
Temp ("C) P I  (X 10-j) ~2 (X 1 o'~) kf kd 
60 Estimate 1 1  1 1  0.03 1 0.02 1 
Std. Error 216 2 16 0.106 0.084 
95 % c.i. -423 ,445 -423 , 445 -0.18 1. 0.243 -0.147, 0.188 
70 Estimate 18 18 0.044 0.032 
Std. Error nee. n.e. 0.074 0.060 
95 % c.i. n.e. n.e. -0.105, 0.194 -0.088, 0.152 
80 Estimate 10 10 .I37 0.066 
Std. Error n.e. me. .009 0.003 
95 % c.i. n. e. me. 0.119. 0.154 0.059, 0.072 
t 0 Charcoal 
! Charcoal and Tissue 
Time (sec) 
Figure 4.8. Adsorption of OTC from charcoaVdextran soiution in the presence and 
absence of porcine tissue. 
Table 4.18. Preliminary grid search estimates used for PROC NLM estimation of 
parameters for the biexponential model of OTC -BSA/Tissue binding. 
Grid Search Estimates Used 
Parameters 
Solution PI (X lo3)  ~2 (X a P 
- -- 
ALL 10 to 90 by 20 10 to 50 by 20 .OM to 0.024 by 0.001 to 0.005 
0.002 by 0.002 
Table 4.19. Parameter estimates obtained for biexponential model of OTC- 
B SA/Tissue binding. 
- 
Parameter Estimates 
Solution PI (x 1 0") ~2 (X lo") a I3 
charcoal - 
BSA 
BSA + 
NaCl 
BSA + SP 
BSA + STP 
Tissue 
Tissue + SP 
Estimate 71 
Std. Error 5 
95 % c.i. 59 . 83 
Estimate 9 
Std. Error 10 
95Ohc.i. 66,107 
Estimate 79 
Std. Error 9 
95Nc.i .  61,97 
Estimate 76 
Std. Error 9 
95 9'0 c.i. 58, 97 
Estimate 87 
Std.Error 6 
95 % c.i. 75, 99 
Estimate 71 
Std. Error 3 
95 % c.i. 65, 77 
Estimate 64 
Std. Error 29 
5. DISCUSSION 
5.1 Chromatographic Selectivity of Organic Solvents for OTC and Degradation 
Compounds 
Application of the solvent classification scheme of Snyder (1978) for determining 
the elution strength of binary solvent systems was unable to accurately predict the 
chromatographic retention time of O K .  Trial and error buffer formulation was required 
to develop binary solvent systems of equivalent eluting strength for OTC. Tbis apparent 
discrepancy was reproducible, and may be attributed to the alteration of the normal bulk 
properties of the base solvent or ion-pairing (Glajch et al., 1980). Differences in 
conformation have been show to have dramatic effects on polarity of tetracyclines. and 
are a function of their environment (Stezowski, 1976). Casey and Yasin ( 1985) as cited 
by Khan et al. (1 987) reported that in deuterated DMSO, the enone ring of P-apoOTC 
assumes a half-chair conformation with the 4s. 4aS. and 12aR substituents in the axial 
position. whereas a-apoOTC occurs as a mixture of conformers with at least one of the 
1s. 4aS. or 12aS substituents in the axial position. This may result in different 
intramolecular interactions between proximal Functional groups. 
Fitting the obtained COF data to quadratic and cubic models was unable to 
provide equations that accurately described the resolving power of the quaternary 
solvent systems. Quenouille (1959) had stated that polynomial models do not account 
for components in the mobile phase that are inen or have additive effects. and that a 
more complicated model would be needed to fit the data. Snee (1979) had proposed 
several models that can overcome these effects; these alternative models were not 
investigated as some of the tested mobile phases resulted in good chromatographic 
separation of OTC from the degradation compounds. Naidong et al. (1990) achieved 
good separation of the four compounds using a poly(styrene-divinylbenzene) column 
(250 x 4.6 rnm I.D.) maintained at 60°C using a one step gradient elution with a five- 
component pH 7.5 mobile phase. The mobile phase used in the present method offers 
the advantage of being simpler (triphasic mixture), and isocratic elution at ambient 
temperature is utilized. 
5.2 Recovery of OTC and Degradation Compounds from Aqueous and Tissue 
Matrices 
The extraction of OTC degradation compounds from aqueous and tissue matrices 
resulted in poor and irreproducible recoveries. Spurious peaks were not evident in the 
chromatograms, providing evidence that the breakdown and subsequent formation of 
other compounds did not occur. The utilization of different eluting solvents (i-e. 
acetonitrile. tetrahydrofuran) did not improve these recoveries. The present findings 
agree with Law et al. (1992) who had reported that elution of some hydrophobic 
material from RP C18 cartridges was more facile with methanol than acetonitrile. 
Hydrophobic interaction is therefore not the only retention mechanism operating in this 
recovery system, and other secondary interactions are also present. Mulders and Van de 
Lagemaat (1989) reported that the presence of residual silanols on C1s cartridges 
resulted in significant adsorption of tetracycline drugs onto the cartridges, resulting in 
reduced recoveries. The mechanism of interaction can be ionic (Law et al., 1992) or 
hydrogen bonding (Law and Weir, 1992). Drug recovery may also be reduced due to 
specific drug-matrix or cartridge-matrix interactions (Law and Weir. 1992), whereby 
materials present in the matrix may interfere with the hydrophobic interaction between 
the compound and the CIs packing. Solid-phase extraction of low concentrations of 
OTC degradation products, particularly a- and P-apoOTC. was not possible with the 
present method. 
5.3 Mechanism of Water Activity Effects upon OTC Degradation 
The kinetics o f  chemical reactions tend to be at a maximum at water activities of 
0.6-0.8 (Labuza, 1980). Below this range, the decrease in solute and water mobility will 
effectively hinder reactions (Yoshioka et d.. 1992). Above this range, the effective 
solute concentration decreases due to increased free water and water of hydration, both 
being available for chemical reactions. Consequently, both of these phenomena decrease 
the rate of reaction. Thus, changing the water content of a matrix affects degradation by 
two general mechanisms; a concentration effect and a solute/water mobility effect. 
Water mobility is commonly expressed in terms of r,, . which is referred to as 
correlation time or relaxation time; TI, which is known as spin-lattice relaxation time and 
a,, which is water activity (Yoshioka et al., 1995). Relaxation time refers to the time for 
a system initially at equilibrium to reach a new equilibrium when an external force is 
applied to the system. T is a measure of the mobility of highly mobile water. whereas T 1 
represents the average mobility of highly mobile water and bound water. r is inversely 
related to water content, whereas T1 is directly related to water content. r is shown to 
be directly related to the inverse of T 1 (Yoshioka et al, 1992). Water activity is also 
related to water content, though it does not appear to have a definable relationship with 
r or T 1 (Warmbier et al., 1976). Values of r will differ for free water, water of 
hydration, and bound water (Yoshioka et al., 1995). r, for bulk water at 25°C is given 
as 8 picoseconds (Franks, 1983). Bound water exhibits a r value greater than hydration 
water, which in turn is greater than bulk water. The relationship of the rate of drug 
degradation to r or T is dependent on the order of the reaction r correlates with f i r -  
order (or pseudo-fist order) reactions, whereas T 1 correlates with second-order 
reactions (Yoshioka et al., 1992). Thus, the rate of OTC degradation is theoretically 
dependent upon r, and not G. Rates of reactions in matrices of the same a, but different 
components can significantly differ (Warmbier et ai., 1976). Practically. however, a. 
data are easier to obtain than other water mobility data. 
Bell and Labuza (1 994) had reported that as the a. of a system decreased to 
approximately 0.6, the rate of most reactions increased with concurrent increase in E, 
and AH, and decrease in AS. At 60 and 70°C, the mean rate of OTC degradation tended 
to be greater (0.05 < p < 0.20) in solutions of decreased a. versus control. At 80aC, no 
trend was apparent. Contrary to Bell and Labuza (1994). E,'s and AH's decreased with 
increasing a,, but there was an apparent decrease in entropy. As water mobility is 
lowered, the medium decreases entropy due to an increase in order of the solvent 
molecules (Duckworth , 198 1). There was an apparent increase in bh at water activities 
below 1.0, which does agree with Bell and Labwa (1994). This apparent discrepancy is 
in agreement with Labwa (1 980). illustrating that the phenomena of enthalpy/enrropy 
compensation occurs in systems of similar properties. Bell and Labuza (1994) had stated 
that at a lower h, the potential for a change in system properties exist. This is due to 
the decrease in the product formation constant w*). The product formation constant 
was defined in equation 2.3 as: 
- K* - [A*] [A1 
where A* and A are concentrations of the drug in the activated state and non-activated 
state, respectively. A* will remain extremeIy small and will not change due to its 
unstable nature. A however will increase, and thus K* should decrease. The free 
energy change as defined in equation 2.6: 
A G * = - R T h ( K * )  
will increase. Since entropy must decrease (due to decreased solvent mobility). enthalpy 
and subsequent E, must increase. As a result, enthalpy/entropy compensation may not 
be seen; however. this was not the case for OTC degradation. It is known, however. 
that the particular solute used will alter the relationship between water activity and water 
mobility (Wmbier  er al.. 1976). and that glycerol solutions tend to have higher solvent 
mobilities than solutions having their a. adjusted using different solutes. This may 
account for the data discrepancy of this study with that of Bell and Labuza ( 1994). 
Enthalpylentropy compensation is a phenomenon whereby in a series of related 
reactions involving minor changes in solvent. enthalpies and entropies will vary 
dependently with each other (Letner. 1955). Thus. large AH values accompany large AS 
values. This relationship, if linear. is evidence that the mechanism of the reaction is the 
same for all tested series (Leffler, 1955). The high degree of correlation obtained 
between AH and AS for OTC degradation (Figure 4.4) indicated that the reaction 
mechanism did not differ under all tested conditions (Leffler. 1955). The isokinetic 
temperature (337 K = 64°C) revealed that below this temperature. degradation of OTC 
by this mechanism was dominated by changes in enthalpy, whereas above this 
temperature, changes are dominated by changes in entropy (Leffler, 1955). The changes 
in the thermodynamic parameters indicated that the kinetics of the reaction were affected 
to a measurable extent while the reaction mechanism remained the same. 
5.4 Buffer Effects Upon OTC Degradation 
Vej-Hansen et a. .  (1978) were the first researchers to perform a limited 
systematic study of the effect of different buffers upon OTC degradation. They had 
concluded that acetate buffer over a range of 0.05 to 0.5 M had a significant though 
minor effect upon the rate of OTC degradation. At 60°C in pH 5.63, 0.05 M acetate 
buffer, they reported that tb, was equivalent to 0.0055 min.", which is just below the 
range of significance of the compiled statistics for pH 5 .5 .  0.05 M acetate buffer 
obtained in this study as shown in Table 4.12 . 
OTC is subject to general acid-base catalysis (Comors et d.. 1986). General 
acid-base catalysis is a reaction whereby a compound aids in proton transfer during the 
formation of the activated state in a reaction and is the rate limiting step (Jencks, 1969). 
The activity of a general acidhase catalyst is related to its pKa; plots of log k l ~ a l  as a 
fhction of pKa are positive for general base catalysts (i.e. the larger the pKa, the greater 
the activity) and negative for general acid catalyst (i.e. the larger the pKa, the less the 
activity). At pH 5.5, the predominant phosphate species is &PO3* , which has a pKa of 
ca. 7.2. Acetate has a pKa of 4.4. OTC degradation significantly (p < 0.05) increased in 
the presence of orthophosphate at pH 5.5, with an apparent linear relationship between 
phosphate concentration and IC,,~. In contrast, analysis of covariance indicated that 
acetate had a negligible effect upon th .  I t  thus can be concluded that OTC degradation 
is catalyzed by compounds that can act as general base catalysts. At pH 5.5, the acid 
degradation mechanism shown in Figure 2.3 would be the preferred one. Though the 
mechanism is acid catalyzed, the rate-limiting step requires removal of a proton (C5a - 
H), with subsequent dehydration at C-6. 
Phosphate buffer was found to have different kinetic effects upon OTC 
degradation, depending upon the pH. Vej-Hansen et al. ( 1978) found that at pH's 1.6-3. 
no catalytic effect was apparent, whereas at pH 6.4-7.7, a catalytic effect over the range 
of 0.01 to 0.05 M is apparent. At pH 6.46, they obtained data for k, and kwpl of 0.0054 
and 0.29 mid, respectively. At pH 5.5, k,, and bar of -0.0049 and -0.132 mid'  were 
obtained in the present study. The two k, values were comparable. Due to dfierent 
proportions of the active base at pH 5.5 and pH 6.46, comparisons of the kWal would 
not be valid. 
Increasing the phosphate buffer concentration decreased entropy. The decrease 
in entropy can be due to an increased ordering of the medium surrounding the reactants- 
products. As phosphate does act as a general base catalyst for OTC degradation. it 
would have to be aligned with OTC in order to be able to participate in the reaction. 
hence the loss in entropy. Enthalpy/entropy compensation was exhibited. which is 
evidence that the reaction mechanism was not altered. only enhanced. The extraction of 
the C-5 H appears to be the predominant rate limiting step in the degradation of OTC. 
5 .5  Polymeric Phosphate Effects Upon OTC Degradation 
In general, polymeric phosphates decreased k,-,*, with SH significantly (p < 0.05) 
decreasing bh at dl tested temperatures. The secondary kinetic parameters did not 
qualitatively differ from that of the acetate buffer control. This, in combination with the 
fact that enthalpy/entropy compensation was exhibited, indicated that the reaction 
mechanism was not altered, and that the compounds did not appear to interact with 
O K .  Higuchi and Bolton (1959) reported that sodium hexametaphosphate exhibits 
negligible interaction with OTC. This indicates that the reaction mechanism was 
inhibited indirectly by the polymeric phosphates. Above 0.0 1 MI, the effect was not 
concentration dependent as there was no difference in tb, over the five-fold range of 
concentrations tested. The decrease in tb, was more pronounced as the chain length of 
the polymeric phosphates increased. Polymeric phosphates are used as detergent aids; 
one of the mechanisms for their effectiveness is the ability to form ion spheres around 
dirt particles (Toy and Walsb 1987). The size of ion spheres are independent of 
concentration. Though not a tme complex, the presence of these spheres may interfere 
with the acid-catalyzed degradation of OTC. These ion spheres would affect molecular 
motion; techniques capable of measuring this motion (e.g. NMR) could be utilized to 
verify this speculation. 
5.6 Ionic Strength Effects Upon OTC Degadation 
Increasing phosphate buffer concentration from 0.05 to 0.1 M increased b,. 
This was shown to be due to the general base catalytic effect of phosphate buffer. The 
addition of NaCl to 0.05 M phosphate buffer did not have any effect upon k,b. This is 
evidence that ionic strength does not affect the transition state during OTC degradation 
(Comors, 1986), implying that the reaction does not undergo a change in ionization 
state. As shown in Figure 2.3, degradation of OTC by the proposed mechanism does not 
involve a change in ionic nature, thereby substantiating literature stating that this is a 
possible mechanism in OTC degradation. 
There was a slight decrease in entropy upon addition of NaCI. The addition of 
NaCl would effectively increase the polarity of the medium (Connors, 1986). As OTC 
possesses polar functional groups, this would have resulted in some degree of increased 
ordering around the molecule. This indicates that minor changes in the matrix polarity 
(via addition of non-reactive ionic compounds) would not have an extensive effect upon 
kah given that water availability is still adequate. 
5.7 Calcium Chloride Effects Upon Thermal Stability of OTC 
Increasing the CaClz concentration fkom 0 to 0.1 M decreased l h  by 
approximately, 3, 4 and 5 fold at 60, 70 and 80°C respectively in 0.1 M acetate buffer. 
Additionally. the E, decreased to 15 kcallmol. Tetracycline forms stable complexes with 
most multivalent cations (Albert and Rees, 1956; Newman and Frank, 1976). The log 
value of the K,s for the formation of ~ e "  . ~ e "  , blg2' and ca2- complexes were 
reported to be 9.1, 5.6 (Albert, 1953), 3.8 (Albert and Rees, 1956) and approximately 1. 
respectively (Higuchi and Bolton, 1959). Calcium binds via the C- 10 and C- 1 1 oxygens 
forming primarily a 1 : 1 complex, a second cation can add to the C- 12 and C- 1 positions. 
though 2: 1 complexes with OTC form much less readily (Newman and Frank, 1976). 
The binding of the C- I0 and C- I 1 sites would interfere with the proposed degradation 
mechanism by disrupting C- 1 1 and C- 12 enolization, which leads to aromatization of the 
C and D rings of the moiecule and contributes to the driving force for the E2 elimination 
reaction at the C-5a:C-6 position. 
The formation constant for the C ~ ~ - - O T C  complex is not high relative to other 
ions, with log values of approximately 1-2 (Higuchi and Bolton, 1959), though it is 
thermally stable (Sina et al., 1974). There is no published information on the effects of 
temperature on formation of the complex itself. Increasing the ca2' concentration would 
increase the relative amount of C ~ ~ + - O T C  complexes by way of an equilibrium shift, 
thereby decreasing bh, which is evident from the compiled data in Table 4.11. 
The addition of CaClz led to a dramatic decrease in entropy. As has been 
reported, OTC does form chelates with calcium and other cations. The formation of a 
chelate means a loss in the degree of ordering, hence the loss of entropy. As 
enthaipy/entropy compensation is still being exhibited, this implies that other mechanisms 
of OTC degradation are not occurring to an extent that measurably affect the kinetics of 
the reaction. This indicates that other degradative mechanisms are not favoured under 
the given reaction conditions. 
Because of their ability to bind calcium, tetracyclines tend to accumulate in bone: 
a single therapeutic dose of tetracycline would last for at least 150 days in bone tissue 
(Van Brackle et al., 1994). In animals receiving prolonged treatment with OTC. it is a 
safe assumption that the amount of accumulation would be substantial. In products 
incorporating mechanically deboned meat (MDM), it is conceivable that bone particles 
are incorporated into the mixture. which may lead to potentially large amounts of 
thermally stable OTC in foodstuffs. Though pork products containing MDM are not 
common (Campbell and Kemy, 1994), rendering is. Rendering is used to create pork 
byproducts, lard being the most common but also water soluble flavour concentrates. 
Bones are used in the rendering process. OTC is water soluble. Though current 
literature has not shown studies supporting this, it is reasonable to assume that carry 
over of OTC from bones to water-soluble byproduas is possible. 
5.8 Sodium Nitrite Effects Upon Thermal Stability of OTC 
Nitrite is a reactive molecule that can undergo oxidative, reductive and coupling 
reactions with phenols, mines, thiols and other organic fbnctional groups (Walters and 
West, 1984). In acetate buffer, there were no significant differences in k~,,, though the 
mean bbs increased at 70°C and decreased at 80°C (Table 4.22). 
The addition of NaNOz, however, did result in a decrease in entropy of the 
reaction. This, in addition to the slight changes in tb, implies that NaNOz and/or its 
degradation compounds are by some mechanism coordinating with OTC to react with it. 
The most probable mechanism would be an oxidative type of reaction, due to the 
relatively high oxidizing potential of nitrite. Since enthalpy/entropy compensation was 
exhibited, this implies that the reaction mechanism was not altered. Nitrite thus appears 
to be involved directly or indirectly at the site of the rate limiting step of the reaction. 
5.9 Porcine Tissue Effects Upon Thermal Stability of OTC 
OTC in porcine tissue matrix at pH 5.5 significantly decreased kb at all 
temperatures over that of pH 5.5, 0.1 M acetate buffer. E,, AH and AS were not 
noticeably different from that of pH 5.5, 0.1 M acetate buffer. Additionally, the data 
exhibited enthalpy/entropy compensation, and therefore it can be concluded that the 
mechanism of the reaction was not altered. The observed change in the rates of 
degradation can be attributed to two possible factors: I )  physical limitations on diffusion 
of the reactants due to inconsistencies in the tissue matrix. 2) chemical interference of 
the reaction. One major source of inconsistencies in the tissue matrix would be due to 
the presence of entrapped air pockets in the tissue, which can be as high as 13 % (v/v) in 
comminuted tissue products (Palombo et al., 1991). This may lead to local temperature 
differences within the meat matrix. 
The addition of sodium chloride to OTC solution did not have any significant 
effect upon OTC degradation. However, addition of NaCl to tissue had dramatic effects 
upon khr. At 60°C, kb, increased whereas at 80°C, bs. decreased. Sodium chloride 
does increase the water holding capacity of meat, reduces cooking losses. and aids in the 
formation of a meat gel ( H a m  1960; Clarke et al., 1987). Gels made from isolated 
meat proteins have bulk water of restricted mobility (Yasui et al., 1979), and water 
mobility does dramatically influence the rate of degradative reactions (Yoshioka et al, 
1992. 1995). However. initial decreases in water mobility via changes in a, will initially 
increase the rate of reactions (Table 4.6). which was not the case in the NaCl meat gel. 
NaCl does not have a direct effect upon OTC degradation (Table 4.8), nor should its 
property of slightly altering water mobility via gel formation have an effect upon OTC 
degradation, as was discussed in section 5.3. NaCl does, however, have the ability to 
displace divalent ions (calcium and magnesium) that are bound to muscle fibers (Bozler. 
1955). Relatively large proportions (approximately 25%) of endogenous calcium and 
magnesium are tightly bound to muscle tissue to the extent that they cannot be removed 
by strong chelating agents, such as EDTA (Bozler. 1955). At 60°C, myosin 
denaturation is complete, though myofibriilar protein (actin and actomyosin) 
denaturation is not complete until 75-80°C (Honikel, 1989). at which temperature a 
dramatic rearrangement of the tertiary structure of the protein occurs. It can be 
speculated that at 60°C, since myofibrillar proteins have not denatured, calcium is still 
bound with a relatively high affinity to the muscle proteins, though it can be selectively 
extracted by OTC. The presence of NaCl would act as an electrostatic shield for 
complexation to occur, reducing the amount of complexation. Less OTC would be in 
the thermal stable complex form, resulting in apparent increase in tk. At 80°C. the 
extensive protein denaturation and competitive displacement of calcium and magnesium 
ions from tissue by chloride ions would increase the effective concentration of both 
divalent ions for OTC complexation. This would increase the amount of OTC that exists 
in the thermally stable complex form, thereby decreasing the apparent bb at higher 
temperatures. The change in entropy for this medium was a relatively large negative 
number, which does imply that the OTC structure was restricted. similar to that exhibited 
by CaClz solutions (Table 4.13). 
In porcine tissue. increasing ~ a ' -  concentration to 0.4 M did not have as great an 
impact upon lowering bh as was observed in aqueous solutions; the presence of 0.1 M 
CaClz in acetate buffer had a much greater kb, lowering effect than 0.4 M CaClz in 
porcine tissue. Addition of ca2- to tissue would result in substantial amounts of the ion 
being bound to the tissue (Boder. 1 95 5); this implies that much of the ca2* would, in 
effect, be unavailable for binding with OTC, thereby resulting in the formation of only a 
limited amount of the thermally stable O T C - C ~ ~ *  complex. The relatively small change 
in entropy is hrther evidence that the restricted OTC-C~'+ complexes are not forming to 
a great extent. The use of metal chelating agents (EDTA, STP, SH) increased kh, 
which supported the conclusion that the meat mineral content was the predominant 
influence in OTC degradation. The lack of effect of CaClz in tissue implies that the meat 
matrix is by some mechanism malung the ca2' unavailable for complexing with OTC. It 
has been shown that OTC exhibits a relatively high degree of binding with BSA (log K, = 
3 -85) though the mechanism of this interaction is predominantly hydrophobic, via 
primarily tyrosine and tryptophan residues (Higuchi and Bolton, 1959; Ma et al., 1973). 
Values o f  K, for OTC binding to muscle tissue proteins has not been reported. 
Hydrophobic forces tend to be much weaker than polar attractive forces; intuitively this 
implies that OTC interaction with protein (i.e. tissue proteins) should not effect the water 
mediated degradation of OTC. Due to the relatively small change in entropy, it may be 
cautiously speculated that OTC still continues to form complexes with ca2*. albeit to a 
lesser extent due to protein selectively binding OTC as well as ca2-. With fewer 
complexes formed, the rate of degradation would be higher, as shown in Table 4.12. 
The addition of polyphosp hates to tissues generally increased kh at all 
temperatures. SH significantly (p < 0.05) increased tb, at all temperatures versus tissue 
matrix alone, with the rates being similar to that of SH in buffer solutions. The different 
phosphates had widely varying effects upon the thermodynamic parameters of 
degradation. Sodium phosphate resulted in a decreased AS. Since it is known that 
orthophosphate has only negligible effects upon protein fhctionality in a buffered matrix 
(Lewis et al.. 1986) the effect is due to interaction with OTC directly. It has been 
shown that orthophosphate acts as a genera1 base catalyst of OTC degradation. which is 
an entropy decreasing process. 
SH and SAPP also decreased AS. Table 4.10 revealed that these compounds do 
not act as general base catalysts, and in fact tend to reduce degradation via indirect 
interaction with O X .  SAPP does have an effect on tissue matrices by breaking 
actomyosin complexes (Lewis et al. 1986). The increased protein in solution would 
result in a decreased water mobility in the gel (Hamm, 1960), but it has been shown that 
moderate reductions in water mobility do not atfen OTC degradation dramatically 
(Table 4.6). Phosphates are strong chelators of metal ions, with polyphosphates 
generally being stronger chelaton of metals than that of orthop hosphates (Irani and 
Cdis, 1962). Increasing temperature increases the amount of chelation (Molins. 199 1 ). 
which is believed to be due primarily to a competitive effect between the thermostable 
phosphate-ion complex and the thermolabiie metal ion-biological complexes (Irani and 
Callis. 1962). They are regarded as being effective chelators between pH's 5- 11 (Wazer 
and Callis. 1958). particularly for iron. whereby lower pH increases the association 
constant (ka) between phosphates and iron (Irani and Morgenthaler. 1963 ). 
Polyphosphates are less susceptible to the effects of pH upon their chelating ability than 
onhophosphates (Wazer and Callis, 1958). The logarithm of the association constants of 
onho- and polyphosphates for monovalent cations ranges from 1-2 (Wazer and Callis. 
1958). For divalent cations such as calcium and magnesium orthophosphate forms 
cornpiexes that have log K, of 1-2; pyrophosphate forms complexes that have log K, of 
3-4; and tripolyphosphates form complexes that have log K, of 6-7 (Wazer and Callis. 
1958). Polyphosphates forms complexes with ferric and ferrous ions with log K, of 22- 
25 (Irani and Morgenthaler, 1963). The USDA has reported that the amount of 
calcium, magnesium and iron in meat is 16, 23 and 0.9 1 mg per 1 OOg portion. 
respectively WSDA, 1997). Thus, the complexing of metal ions results in greatly 
reduced formation of thermostable OTC-cation complexes, thereby increasing bh. As 
the koh obtained were similar to that found in buffer done, it can be concluded that 
physical inconsistencies in the tissue matrix did not affect OTC degradation. 
The complexation of EDTA with metal ions is highly dependent upon pH; 
cornplexing is dependent upon the amount of the species (Harris. 199 1 ). At pH 5-6 
(i-e. the approximate pH of postrigor meat) the log Kf for M ~ ~ * ,  ca2-and  el^ are 
approximately 3, 5 and 8 respectively. At pH 5.5, EDTA would be present 
predominantly in the diprotic form. The amount of the monoprotic species, with a pKa 
of 6.16 is approximately 0.2 of the total amount. It thus would have only negligible 
effect upon general base catalysis of OTC (Jencks. 1969). It has also been reported that 
EDTA does not form complexes with OTC (Higuchi and Bolton, 1959). It is assumed 
that upon addition of EDTA to a meat matrix, polyvalent cations would be made 
unavailable for binding by O K ,  preventing the formation of thermally-stable 
complexes. Only the remaining matrix components would interact with OTC. Addition 
of 0.2 M EDTA to the tissue increased the rate of OTC degradation to [evels that were 
not sigruficantly different from that of 0.1 M acetate buffer. This indicated that the 
mineral content of tissue is primarily responsible for the increase in the thermal stability 
of OTC in tissue. which is in agreement with results obtained for the use of 
polyp hosp hates. 
In tissue. the addition of NaNOz significantly increased 16b, at 60°C. whereas it 
significantly decreased it at 80°C (p c 0.05). The E, decreased. though the fit of the 
kinetic parameters upon the isokinetic temperature line indicated that the mechanism for 
the degradation of OTC did not change. The drop in E,, however. revealed that the rate 
limiting step for the degradation of OTC (elimination of the C-ja proton) has been 
affected. Nitrite is present in too smail a quantity to effect the physical structure of 
tissue; as well nitrite does not appear to have a direct effect upon OTC as indicated by 
the bbs obtained from solution experiments. This implies that nitrite affects and is 
affected by the tissues chemically, which subsequently affects the rate of OTC 
degradation. Nitrite tends to have minimal reactivity in a matrix unless reducing agents 
are present (Ando. 1973). The main component of tissue that has an influence upon kb, 
is its mineral content. The presence of nitrite reduces the amount of non-heme iron in 
cooked meat as compared to no nitrite controls (Schncker and Mler. 1983). Several 
other unidentified nitrite reaction products also exist. some of which have been shown to 
have reducing properties (Sebranek et ai.. 1978). though there is no documentation that 
indicates the relative reactive strength of these chemical entities. The decrease in 
entropy was the largest among all treatments. The decrease indicates that the matrix 
(tissue and water) or OTC itself became much more structured during the course of the 
reaction. Physical changes in the matrix are unlikely, implying that the structure of OTC 
has become restricted by interaction with reaction products of nitrite and the tissue. The 
relatively low E, of the reaction indicates that OTC degradation in this matrix is 
ncreases temperature insensitive relative to other tested matrices (e.g. in tissue only, k,i, i 
ten-fold From 60 to 80°C, whereas in tissue with Na.N02, kt,, increases threefold). 
Though nitrite does increase the rate of OTC degradation at lower temperatures, the 
large decrease in entropy for the reaction limits the temperature-induced increases in bh. 
Thus. OTC residues in cured meat products. in the absence of other influencing factors. 
would not be expected to change greatly during cookery practices. 
5. LO Formation of OTC Degradation Compounds 
The degradation of OTC under most experimental conditions resulted in the 
presence of several unknown chromatographic peaks during subsequent analysis. 
Previous evidence has indicated that the rate limiting step in OTC degradation is 
predominantly the E2 elimination mechanism at the C-5a:C-6 bond. However, the end 
product of this reaction is also labile, as evident from the several chromatographic peaks. 
suggesting the presence of several components in the reaction mixture. In distilled water. 
the amounts of these unknown compounds was less, and there was limited success in 
being able to monitor the formation of a compound responsible for a peak eluting at ca. 
12 minutes under the given analytical conditions. At all temperatures, there was an initial 
increase in the unidentified compound, followed by a decrease. The logic for this trend 
is that assuming that the formation and degradation of this compound obeys first-order 
kinetics. initial formation of the compound would be favoured due to the large amount of 
the reactant (i-e. OTC). As the reaction proceeds, the amount of OTC decreases: less 
product forms. and the rate of degradation is greater than the rate of formation resulting 
in a net decrease in the formation of the product. One common approach to quantify 
these rates is through application of the biexponential model (Shargel and Yu. 1093). 
SAS offers a procedure (PROC NLIN) that can enable the estimation of the parameters 
for this model through an iterative procedure. In this procedure, initial estimates of the 
parameters are supplied by the user; the program subsequently performs a series of minor 
manipulations on the estimates in an attempt to minimize the differences between the 
given data and predicted values (i.e. minimize the residual sum of squares) using the 
parameter estimates. Utilizing the program algorithm, these manipulations continue until 
the differences no longer change; the reported values of the estimates are the last 
manipulated values. Variances of these estimates are not subject to the same protocols 
as for linear models, and are regarded as approximations only (SAS Institute Inc., 1989). 
The major problem associated with this method is that it is not known whether the 
estimates provided are the result of a global minima in residual deviations, or a local 
minima, in which case the parameter estimates are invalid. It was found that by altering 
the initial parameter estimates, the final obtained parameter estimates would differ 
substantially. Table 4.1 7 shows that the variances associated with the parameters are 
usually much larger than the estimate itself In several instances, PROC WIN could not 
provide approximations of the standard errors. Determination of the goodness of fit of 
the model through application of a lack-of-fit test revealed that the models at all 
temperatures exhibited significant lack-of-fit, indicating that the biexponential model is 
not appropriate for modelling the formation of unknown degradation compounds. The 
implications of this are that OTC degrades by several mechanisms and/or by different 
kinetics. Also, the biexponential model assumes that compound formation and 
degradation obey first-order kinetics, which may not be correct in this case. A 
mathematical model could be obtained only if sufficient data could be collected 
accounting for the predominant degradation compounds and possible reaction 
mechanism. 
5.1 1 OTC Binding to BSAITissue 
Application of the biexponential model to the competitive binding data for OTC 
tissue/BSA data was valid. Standard errors of the estimates were generally less than the 
values of the estimates. Determination of the goodness-of-fit of the models by 
application of lack-of-fit tests indicated that lack-of-fit was insignificant (Le. hnher 
improvements in the model would not be useful). However, the P values (coefficients of 
OTC dissociation from tissue/BSA) obtained @om all treatments were not significantly 
different fiom each other. 
Addition of NaCl or STP, a relatively strong chelating agent, did not affect the P 
term greatly in BSA solutions, which suggested that neither electrostatic shielding nor 
metal chelating action affected OTC binding to BSA; thus, the predominant attractive 
forces between OTC and BSA are not ionic in nature, nor are metal chelating effects 
involved. This implies that the binding of OTC to proteins is due to either hydrophobic 
or hydrogen bonding, which is in agreement with Ma et al. (1973). 
It has been shown that when calcium is added to a tissue matrix, the increase in 
thermal stability of OTC is not as great if only buffer solution were used as a matrix.. 
Calcium and magnesium do have strong affinities for contractile proteins (Boder. 1955). 
Kinetic data obtained from this project provided evidence that binding of OTC to 
calcium is inhibited due to the competition between protein and OTC for calcium. 
Further evidence for this is that the addition of phosphate, a weak metal chelator. to 
porcine tissue homogenate, resulted in a dramatic increase in the P-term, showing that 
OTC was not held with as great an affinity to the tissue. Phosphate in pH buffered 
solution would not have a significant effect upon protein solubilities or functional 
properties of tissues (Lewis et al, 1986). thus the phosphate effect can be attributed to its 
other chemical properties (i-e. metal chelation). The metals chelated would include 
calcium and magnesium. As a result of chelation, the ions attached to the proteins would 
be unavailable for binding to OTC. 
6. CONCLUSIONS 
A method for the separation and quantification of oxytetracycline and related 
compounds through the application of isocratic reversed-phase liquid chromatography 
was developed. Extraction and quantification of common OTC degradation compounds 
from aqueous and tissue media was not as viable as it was for OTC. This was attributed 
to the potential degradation of the compounds in the matrices, or to the inability of the 
extraction methodology to separate the compounds £?om the matrices. Tissue matrices. 
due to their inherent complexity, decreased the extent and precision of OTC and 
degadation compound extraction. Monitoring the formation of degradation compounds 
would give hrther insight into the reactions occurring in food matrices. Funher research 
to develop a viable extraction method for these compounds would be needed before 
successhl monitoring of these compounds in tissues can occur. 
The effects of heat. water activity, salts, phosphates, sodium nitrite and porcine 
tissue upon the rate of OTC degradation were determined. The rates of degradation 
were found to be significantly affected by the presence of phosphates (monomeric and 
polymeric), heat, nitrite. calcium and tissue. Water activity and salt levels of interest to 
meat processors did not appreciably effect the rate of OTC degradation. The secondary 
kinetic parameters obtained indicated that the rate limiting step in the degradation of 
OTC was the same for all processing condition combinations. 
Water activities adjusted by means of glycerol did not significantly alter k,h. 
though changes in the secondary kinetic parameters were noted. OTC degradation is 
affected by changes in aw. though effects on kb, would not be apparent until lower a& 
or media of Iower water mobility were utilized. Trends in bh changes were consistent 
with current theories on the effects of a. upon reaction kinetics. 
Ortho phosphate and polymeric phosphates exhibited different effects upon OTC 
degradation. Monomeric phosphates catalysed the degradation of OTC, via general acid 
base catalysis. Polymeric phosphates decreased the rate of OTC degradation. The 
decrease in lbh was dependent upon the type of polymeric phosphate used but not its 
concentration. The formation of ion spheres was a speculative explanation for this 
phenomenon. 
In tissue, polymeric phosphates significantly increased k,,*. Polymeric 
phosphates are strong chelating agents, and induced similar effects as EDTG another 
strong chelating agent. By making cations unavailable for OTC complexation 
themostable complexes could not be formed, resulting in increased Lba. This indicated 
that the predominant mechanism by which OTC gains thermal stability in tissues is due to 
the minerd content. 
The addition of calcium dramatically decreased tb, in solution. Previous 
research has shown that OTC forms thermally stable cheiates with calcium. The large 
decrease in entropy for thermal degradation of OTC in the presence of calcium data 
provided evidence of the formation of these complexes. The complexes interfere with 
OTC degradation by inhibiting arornatization of the C andD rings, which is the driving 
force for the rate limiting E2 elimination reaction. In tissue, the decrease in k~,, was not 
as dramatic. due to competitive binding of calcium by both OTC and tissue proteins. 
Competitive binding studies indicated that addition of chelating agents displaces OTC 
from protein binding mediated by metal complexation. 
Nitrite in solution had a minimal effect upon the rate of OTC degradation, though 
secondary kinetic data indicated that nitrite is, in some manner, interacting with O K .  
When added to porcine tissue, nitrite had a dramatic effect upon kb.. Nitrite in the 
presence of reductants forms the active nitrosating agent in addition to other 
compounds. The low E, indicated that the reaction was relatively independent of 
temperature. The low AS value revealed that a steric factor is involved in the reaction 
(i-e. proper alignment of OTC with the reactive nitrite-derived compounds). 
The addition of sodium chloride to an aqueous solution of OTC did not 
significantly alter bh. Addition of sodium chloride to tissue, however, sigruficantly 
increased OTC degradation at 60°C, and significantly decreased it at 80°C. 
Electrostatic shielding of divalent ions &om OTC at low temperatures and displacement 
of divalent cations fkom tissues at high temperatures are believed to be the mechanisms 
occurring to explain this phenomena. 
The presence of enthalpy/entropy compensation revealed that one reaction 
mechanism was the predominant rate limiting step. However. the number of degradation 
compounds that formed during thermal treatment increased as complexity of the reaction 
media increased. Analysis of the formation of one unknown compound revealed that its 
formation and degradation kinetics could not be modelled according to a biexponential 
equation. Subsequent degradation oFOTC following the initial rate limiting step may 
proceed by way of several different mechanisms. 
During meat processing, several of the studied parameters would occur 
simultaneously. To precisely model OTC degradation under such conditions would 
require quantifying interaction effects between the various parameters. This would 
prove impractical, as the number of interactions would be immense. Instead. research 
efforts in this area should be directed towards identifying those interactions that are 
definable (i.e. first- or second-order). Higher-order interactions would be evaluated for 
their potential impact. If the impact is great, then application of several models. 
corresponding to different boundary conditions, may then prove more usehi. These 
models, coupled with estimation of the amount of OTC residues present in raw tissues. 
could then be utilized to estimate the daily intake of OTC as well as the degradation 
products. The results obtained could be used for several purposes, the most notable 
when trying to correlate this data with atypical health patterns in affected populations. 
Aspects of the protocol used in this study could be used for the study of other 
xenobiotics, though each would have its own unique chemistry, requiring modification of 
the procedures used. Much research on the degradation of other antibiotics is 
quantitative in nature, with few systematic studies performed on determining rates o f  
reactions. Systematic studies would provide information more usehl than that obtained 
from absolute quantitative studies for attempting to estimate the extent of breakdown of 
xenobiotics during a given cookery practice. 
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